{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T22:25:01Z","timestamp":1790720701384,"version":"4.1.0"},"reference-count":386,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Gastroenterol Hepatol"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1038\/s41575-025-01147-8","type":"journal-article","created":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T12:48:10Z","timestamp":1763988490000},"page":"331-354","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Regulated necrosis at the crossroads of liver inflammation and cancer development"],"prefix":"10.1038","volume":"23","author":[{"given":"Mihael","family":"Vucur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6970-8731","authenticated-orcid":false,"given":"Vangelis","family":"Kondylis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2334-7790","authenticated-orcid":false,"given":"Petr","family":"Broz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6288-8821","authenticated-orcid":false,"given":"Tom","family":"Luedde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,24]]},"reference":[{"key":"1147_CR1","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.jhep.2023.03.017","volume":"79","author":"H Devarbhavi","year":"2023","unstructured":"Devarbhavi, H. et al. Global burden of liver disease: 2023 update. J. Hepatol. 79, 516\u2013537 (2023).","journal-title":"J. Hepatol."},{"key":"1147_CR2","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1038\/s41575-018-0065-y","volume":"15","author":"RF Schwabe","year":"2018","unstructured":"Schwabe, R. F. & Luedde, T. Apoptosis and necroptosis in the liver: a matter of life and death. Nat. Rev. Gastroenterol. Hepatol. 15, 738\u2013752 (2018).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"1147_CR3","doi-asserted-by":"publisher","first-page":"3104","DOI":"10.3390\/ijms19103104","volume":"19","author":"S Mihm","year":"2018","unstructured":"Mihm, S. Danger-associated molecular patterns (DAMPs): molecular triggers for sterile inflammation in the liver. Int J. Mol. Sci. 19, 3104 (2018).","journal-title":"Int J. Mol. Sci."},{"key":"1147_CR4","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.molmed.2018.10.007","volume":"25","author":"V Kondylis","year":"2019","unstructured":"Kondylis, V. & Pasparakis, M. RIP kinases in liver cell death, inflammation and cancer. Trends Mol. Med. 25, 47\u201363 (2019).","journal-title":"Trends Mol. Med."},{"key":"1147_CR5","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.ejca.2022.03.010","volume":"168","author":"SH Loosen","year":"2022","unstructured":"Loosen, S. H. et al. An elevated FIB-4 score is associated with an increased incidence of liver cancer: a longitudinal analysis among 248,224 outpatients in Germany. Eur. J. Cancer 168, 41\u201350 (2022).","journal-title":"Eur. J. Cancer"},{"key":"1147_CR6","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1002\/hep.21178","volume":"43","author":"RK Sterling","year":"2006","unstructured":"Sterling, R. K. et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection. Hepatology 43, 1317\u20131325 (2006).","journal-title":"Hepatology"},{"key":"1147_CR7","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/s41420-024-02116-x","volume":"10","author":"X Wu","year":"2024","unstructured":"Wu, X., Cao, J., Wan, X. & Du, S. Programmed cell death in hepatocellular carcinoma: mechanisms and therapeutic prospects. Cell Death Discov. 10, 356 (2024).","journal-title":"Cell Death Discov."},{"key":"1147_CR8","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/s41418-017-0012-4","volume":"25","author":"L Galluzzi","year":"2018","unstructured":"Galluzzi, L. et al. Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018. Cell Death Differ. 25, 486\u2013541 (2018).","journal-title":"Cell Death Differ."},{"key":"1147_CR9","doi-asserted-by":"publisher","first-page":"9682","DOI":"10.3390\/ijms21249682","volume":"21","author":"L Shojaie","year":"2020","unstructured":"Shojaie, L., Iorga, A. & Dara, L. Cell death in liver diseases: a review. Int J. Mol. Sci. 21, 9682 (2020).","journal-title":"Int J. Mol. Sci."},{"key":"1147_CR10","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.celrep.2013.07.035","volume":"4","author":"M Vucur","year":"2013","unstructured":"Vucur, M. et al. RIP3 inhibits inflammatory hepatocarcinogenesis but promotes cholestasis by controlling caspase-8- and JNK-dependent compensatory cell proliferation. Cell Rep. 4, 776\u2013790 (2013).","journal-title":"Cell Rep."},{"key":"1147_CR11","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ccr.2006.12.016","volume":"11","author":"T Luedde","year":"2007","unstructured":"Luedde, T. et al. Deletion of NEMO\/IKK\u03b3 in liver parenchymal cells causes steatohepatitis and hepatocellular carcinoma. Cancer Cell 11, 119\u2013132 (2007).","journal-title":"Cancer Cell"},{"key":"1147_CR12","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.ccell.2015.10.001","volume":"28","author":"V Kondylis","year":"2015","unstructured":"Kondylis, V. et al. NEMO prevents steatohepatitis and hepatocellular carcinoma by inhibiting RIPK1 kinase activity-mediated hepatocyte apoptosis. Cancer Cell 28, 582\u2013598 (2015).","journal-title":"Cancer Cell"},{"key":"1147_CR13","doi-asserted-by":"publisher","first-page":"2710","DOI":"10.1038\/s41418-019-0330-9","volume":"26","author":"S Krishna-Subramanian","year":"2019","unstructured":"Krishna-Subramanian, S. et al. RIPK1 and death receptor signaling drive biliary damage and early liver tumorigenesis in mice with chronic hepatobiliary injury. Cell Death Differ. 26, 2710\u20132726 (2019).","journal-title":"Cell Death Differ."},{"key":"1147_CR14","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.ccell.2017.08.010","volume":"32","author":"Y Boege","year":"2017","unstructured":"Boege, Y. et al. A dual role of caspase-8 in triggering and sensing proliferation-associated DNA damage, a key determinant of liver cancer development. Cancer Cell 32, 342\u2013359.e10 (2017).","journal-title":"Cancer Cell"},{"key":"1147_CR15","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1002\/hep.23479","volume":"51","author":"A Weber","year":"2010","unstructured":"Weber, A. et al. Hepatocyte-specific deletion of the antiapoptotic protein myeloid cell leukemia-1 triggers proliferation and hepatocarcinogenesis in mice. Hepatology 51, 1226\u20131236 (2010).","journal-title":"Hepatology"},{"key":"1147_CR16","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.jhep.2012.01.027","volume":"57","author":"H Hikita","year":"2012","unstructured":"Hikita, H. et al. Bak deficiency inhibits liver carcinogenesis: a causal link between apoptosis and carcinogenesis. J. Hepatol. 57, 92\u2013100 (2012).","journal-title":"J. Hepatol."},{"key":"1147_CR17","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1053\/j.gastro.2011.08.037","volume":"141","author":"C Liedtke","year":"2011","unstructured":"Liedtke, C. et al. Loss of caspase-8 protects mice against inflammation-related hepatocarcinogenesis but induces non-apoptotic liver injury. Gastroenterology 141, 2176\u20132187 (2011).","journal-title":"Gastroenterology"},{"key":"1147_CR18","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1002\/j.2040-4603.2013.tb00507.x","volume":"3","author":"ME Guicciardi","year":"2013","unstructured":"Guicciardi, M. E., Malhi, H., Mott, J. L. & Gores, G. J. Apoptosis and necrosis in the liver. Compr. Physiol. 3, 977\u20131010 (2013).","journal-title":"Compr. Physiol."},{"key":"1147_CR19","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1053\/j.gastro.2014.07.018","volume":"147","author":"T Luedde","year":"2014","unstructured":"Luedde, T., Kaplowitz, N. & Schwabe, R. F. Cell death and cell death responses in liver disease: mechanisms and clinical relevance. Gastroenterology 147, 765\u2013783.e4 (2014).","journal-title":"Gastroenterology"},{"key":"1147_CR20","unstructured":"Green, D. R. Cell Death: Apoptosis and other Means to an End 2nd edn (Cold Spring Harbor Laboratory Press, 2018)."},{"key":"1147_CR21","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/cdd.2017.179","volume":"25","author":"H Kalkavan","year":"2018","unstructured":"Kalkavan, H. & Green, D. R. MOMP, cell suicide as a BCL-2 family business. Cell Death Differ. 25, 46\u201355 (2018).","journal-title":"Cell Death Differ."},{"key":"1147_CR22","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/sj.cdd.4402028","volume":"14","author":"Q Bao","year":"2007","unstructured":"Bao, Q. & Shi, Y. Apoptosome: a platform for the activation of initiator caspases. Cell Death Differ. 14, 56\u201365 (2007).","journal-title":"Cell Death Differ."},{"key":"1147_CR23","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1038\/nature08229","volume":"460","author":"PJ Jost","year":"2009","unstructured":"Jost, P. J. et al. XIAP discriminates between type I and type II FAS-induced apoptosis. Nature 460, 1035\u20131039 (2009).","journal-title":"Nature"},{"key":"1147_CR24","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1007\/s10495-017-1413-z","volume":"22","author":"M Sachet","year":"2017","unstructured":"Sachet, M., Liang, Y. Y. & Oehler, R. The immune response to secondary necrotic cells. Apoptosis 22, 1189\u20131204 (2017).","journal-title":"Apoptosis"},{"key":"1147_CR25","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1038\/ncb3596","volume":"19","author":"E Giampazolias","year":"2017","unstructured":"Giampazolias, E. et al. Mitochondrial permeabilization engages NF-\u03baB-dependent anti-tumour activity under caspase deficiency. Nat. Cell Biol. 19, 1116\u20131129 (2017).","journal-title":"Nat. Cell Biol."},{"key":"1147_CR26","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/s41577-022-00760-x","volume":"23","author":"S Marchi","year":"2023","unstructured":"Marchi, S., Guilbaud, E., Tait, S. W. G., Yamazaki, T. & Galluzzi, L. Mitochondrial control of inflammation. Nat. Rev. Immunol. 23, 159\u2013173 (2023).","journal-title":"Nat. Rev. Immunol."},{"key":"1147_CR27","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1016\/j.cell.2014.11.037","volume":"159","author":"A Rongvaux","year":"2014","unstructured":"Rongvaux, A. et al. Apoptotic caspases prevent the induction of type I interferons by mitochondrial DNA. Cell 159, 1563\u20131577 (2014).","journal-title":"Cell"},{"key":"1147_CR28","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1016\/j.cell.2014.11.036","volume":"159","author":"MJ White","year":"2014","unstructured":"White, M. J. et al. Apoptotic caspases suppress mtDNA-induced STING-mediated type I IFN production. Cell 159, 1549\u20131562 (2014).","journal-title":"Cell"},{"key":"1147_CR29","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nature22393","volume":"547","author":"Y Wang","year":"2017","unstructured":"Wang, Y. et al. Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin. Nature 547, 99\u2013103 (2017).","journal-title":"Nature"},{"key":"1147_CR30","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/nrm.2016.149","volume":"18","author":"R Weinlich","year":"2017","unstructured":"Weinlich, R., Oberst, A., Beere, H. M. & Green, D. R. Necroptosis in development, inflammation and disease. Nat. Rev. Mol. Cell Biol. 18, 127\u2013136 (2017).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1147_CR31","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.immuni.2024.02.011","volume":"57","author":"KE Lawlor","year":"2024","unstructured":"Lawlor, K. E., Murphy, J. M. & Vince, J. E. Gasdermin and MLKL necrotic cell death effectors: signaling and diseases. Immunity 57, 429\u2013445 (2024).","journal-title":"Immunity"},{"key":"1147_CR32","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/nature20558","volume":"540","author":"J Lin","year":"2016","unstructured":"Lin, J. et al. RIPK1 counteracts ZBP1-mediated necroptosis to inhibit inflammation. Nature 540, 124\u2013128 (2016).","journal-title":"Nature"},{"key":"1147_CR33","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/nature20559","volume":"540","author":"K Newton","year":"2016","unstructured":"Newton, K. et al. RIPK1 inhibits ZBP1-driven necroptosis during development. Nature 540, 129\u2013133 (2016).","journal-title":"Nature"},{"key":"1147_CR34","doi-asserted-by":"publisher","first-page":"102891","DOI":"10.1016\/j.sbi.2024.102891","volume":"88","author":"KA Davies","year":"2024","unstructured":"Davies, K. A., Czabotar, P. E. & Murphy, J. M. Death at a funeral: activation of the dead enzyme, MLKL, to kill cells by necroptosis. Curr. Opin. Struct. Biol. 88, 102891 (2024).","journal-title":"Curr. Opin. Struct. Biol."},{"key":"1147_CR35","doi-asserted-by":"publisher","first-page":"15072","DOI":"10.1073\/pnas.1408987111","volume":"111","author":"JM Hildebrand","year":"2014","unstructured":"Hildebrand, J. M. et al. Activation of the pseudokinase MLKL unleashes the four-helix bundle domain to induce membrane localization and necroptotic cell death. Proc. Natl Acad. Sci. USA 111, 15072\u201315077 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1147_CR36","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41577-019-0228-2","volume":"20","author":"P Broz","year":"2020","unstructured":"Broz, P., Pelegrin, P. & Shao, F. The gasdermins, a protein family executing cell death and inflammation. Nat. Rev. Immunol. 20, 143\u2013157 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"1147_CR37","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1016\/j.cell.2023.04.025","volume":"186","author":"KC Barnett","year":"2023","unstructured":"Barnett, K. C., Li, S., Liang, K. & Ting, J. P. A 360\u00b0 view of the inflammasome: mechanisms of activation, cell death, and disease. Cell 186, 2288\u20132312 (2023).","journal-title":"Cell"},{"key":"1147_CR38","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1016\/j.immuni.2019.05.020","volume":"50","author":"N Van Opdenbosch","year":"2019","unstructured":"Van Opdenbosch, N. & Lamkanfi, M. Caspases in cell death, inflammation, and disease. Immunity 50, 1352\u20131364 (2019).","journal-title":"Immunity"},{"key":"1147_CR39","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/s41573-021-00154-z","volume":"20","author":"X Liu","year":"2021","unstructured":"Liu, X., Xia, S., Zhang, Z., Wu, H. & Lieberman, J. Channelling inflammation: gasdermins in physiology and disease. Nat. Rev. Drug Discov. 20, 384\u2013405 (2021).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1147_CR40","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon, S. J. et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149, 1060\u20131072 (2012).","journal-title":"Cell"},{"key":"1147_CR41","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","volume":"171","author":"BR Stockwell","year":"2017","unstructured":"Stockwell, B. R. et al. Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease. Cell 171, 273\u2013285 (2017).","journal-title":"Cell"},{"key":"1147_CR42","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1038\/s41589-020-0613-y","volume":"16","author":"M Soula","year":"2020","unstructured":"Soula, M. et al. Metabolic determinants of cancer cell sensitivity to canonical ferroptosis inducers. Nat. Chem. Biol. 16, 1351\u20131360 (2020).","journal-title":"Nat. Chem. Biol."},{"key":"1147_CR43","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/cr.2017.133","volume":"28","author":"Y Zhang","year":"2018","unstructured":"Zhang, Y., Chen, X., Gueydan, C. & Han, J. Plasma membrane changes during programmed cell deaths. Cell Res. 28, 9\u201321 (2018).","journal-title":"Cell Res."},{"key":"1147_CR44","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41586-021-03218-7","volume":"591","author":"N Kayagaki","year":"2021","unstructured":"Kayagaki, N. et al. NINJ1 mediates plasma membrane rupture during lytic cell death. Nature 591, 131\u2013136 (2021).","journal-title":"Nature"},{"key":"1147_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-06284-z","volume":"14","author":"Y Dondelinger","year":"2023","unstructured":"Dondelinger, Y. et al. NINJ1 is activated by cell swelling to regulate plasma membrane permeabilization during regulated necrosis. Cell Death Dis. 14, 755 (2023).","journal-title":"Cell Death Dis."},{"key":"1147_CR46","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1038\/s44318-024-00055-y","volume":"43","author":"S Ramos","year":"2024","unstructured":"Ramos, S., Hartenian, E., Santos, J. C., Walch, P. & Broz, P. NINJ1 induces plasma membrane rupture and release of damage-associated molecular pattern molecules during ferroptosis. EMBO J. 43, 1164\u20131186 (2024).","journal-title":"EMBO J."},{"key":"1147_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2015.126","volume":"6","author":"M Deutsch","year":"2015","unstructured":"Deutsch, M. et al. Divergent effects of RIP1 or RIP3 blockade in murine models of acute liver injury. Cell Death Dis. 6, e1759 (2015).","journal-title":"Cell Death Dis."},{"key":"1147_CR48","doi-asserted-by":"publisher","first-page":"4346","DOI":"10.1172\/JCI87545","volume":"126","author":"C Gunther","year":"2016","unstructured":"Gunther, C. et al. The pseudokinase MLKL mediates programmed hepatocellular necrosis independently of RIPK3 during hepatitis. J. Clin. Invest. 126, 4346\u20134360 (2016).","journal-title":"J. Clin. Invest."},{"key":"1147_CR49","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.15252\/emmm.201403856","volume":"6","author":"J Gautheron","year":"2014","unstructured":"Gautheron, J. et al. A positive feedback loop between RIP3 and JNK controls non-alcoholic steatohepatitis. EMBO Mol. Med. 6, 1062\u20131074 (2014).","journal-title":"EMBO Mol. Med."},{"key":"1147_CR50","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1002\/hep.26200","volume":"57","author":"S Roychowdhury","year":"2013","unstructured":"Roychowdhury, S., McMullen, M. R., Pisano, S. G., Liu, X. & Nagy, L. E. Absence of receptor interacting protein kinase 3 prevents ethanol-induced liver injury. Hepatology 57, 1773\u20131783 (2013).","journal-title":"Hepatology"},{"key":"1147_CR51","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1002\/hep.28676","volume":"64","author":"S Roychowdhury","year":"2016","unstructured":"Roychowdhury, S. et al. Receptor interacting protein 3 protects mice from high-fat diet-induced liver injury. Hepatology 64, 1518\u20131533 (2016).","journal-title":"Hepatology"},{"key":"1147_CR52","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1042\/CS20140732","volume":"129","author":"MB Afonso","year":"2015","unstructured":"Afonso, M. B. et al. Necroptosis is a key pathogenic event in human and experimental murine models of non-alcoholic steatohepatitis. Clin. Sci. 129, 721\u2013739 (2015).","journal-title":"Clin. Sci."},{"key":"1147_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2016.280","volume":"7","author":"MB Afonso","year":"2016","unstructured":"Afonso, M. B. et al. Activation of necroptosis in human and experimental cholestasis. Cell Death Dis. 7, e2390 (2016).","journal-title":"Cell Death Dis."},{"key":"1147_CR54","doi-asserted-by":"publisher","first-page":"155975","DOI":"10.1016\/j.metabol.2024.155975","volume":"158","author":"MB Afonso","year":"2024","unstructured":"Afonso, M. B. et al. Intricate interplay between cell metabolism and necroptosis regulation in metabolic dysfunction-associated steatotic liver disease: a narrative review. Metabolism 158, 155975 (2024).","journal-title":"Metabolism"},{"key":"1147_CR55","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1146\/annurev-pathmechdis-051122-094016","volume":"19","author":"H Jaeschke","year":"2024","unstructured":"Jaeschke, H. & Ramachandran, A. Acetaminophen hepatotoxicity: paradigm for understanding mechanisms of drug-induced liver injury. Annu. Rev. Pathol. 19, 453\u2013478 (2024).","journal-title":"Annu. Rev. Pathol."},{"key":"1147_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.241","volume":"5","author":"JX Li","year":"2014","unstructured":"Li, J. X. et al. The B-Raf(V600E) inhibitor dabrafenib selectively inhibits RIP3 and alleviates acetaminophen-induced liver injury. Cell Death Dis. 5, e1278 (2014).","journal-title":"Cell Death Dis."},{"key":"1147_CR57","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/s44321-023-00011-z","volume":"16","author":"X Wu","year":"2024","unstructured":"Wu, X., Nagy, L. E. & Gautheron, J. Mediators of necroptosis: from cell death to metabolic regulation. EMBO Mol. Med. 16, 219\u2013237 (2024).","journal-title":"EMBO Mol. Med."},{"key":"1147_CR58","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1053\/j.gastro.2022.09.025","volume":"163","author":"L Dara","year":"2022","unstructured":"Dara, L. No necroptosis in hepatocytes: the final nail in the coffin? Gastroenterology 163, 1492\u20131495 (2022).","journal-title":"Gastroenterology"},{"key":"1147_CR59","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1002\/hep.28225","volume":"64","author":"AT Schneider","year":"2016","unstructured":"Schneider, A. T., Gautheron, J., Tacke, F., Vucur, M. & Luedde, T. Receptor interacting protein kinase 1 (RIPK1) in hepatocytes does not mediate murine acetaminophen toxicity. Hepatology 64, 306\u2013308 (2016).","journal-title":"Hepatology"},{"key":"1147_CR60","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s00335-021-09863-7","volume":"32","author":"AC Ericsson","year":"2021","unstructured":"Ericsson, A. C. & Franklin, C. L. The gut microbiome of laboratory mice: considerations and best practices for translational research. Mamm. Genome 32, 239\u2013250 (2021).","journal-title":"Mamm. Genome"},{"key":"1147_CR61","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2337\/db15-0982","volume":"65","author":"DA Fontaine","year":"2016","unstructured":"Fontaine, D. A. & Davis, D. B. Attention to background strain is essential for metabolic research: C57BL\/6 and the international knockout mouse consortium. Diabetes 65, 25\u201333 (2016).","journal-title":"Diabetes"},{"key":"1147_CR62","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.jcmgh.2021.11.012","volume":"13","author":"S Gallage","year":"2022","unstructured":"Gallage, S. et al. Spontaneous cholemia in C57BL\/6 mice predisposes to liver cancer in NASH. Cell Mol. Gastroenterol. Hepatol. 13, 875\u2013878 (2022).","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"1147_CR63","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1002\/hep.27939","volume":"62","author":"L Dara","year":"2015","unstructured":"Dara, L. et al. Receptor interacting protein kinase 1 mediates murine acetaminophen toxicity independent of the necrosome and not through necroptosis. Hepatology 62, 1847\u20131857 (2015).","journal-title":"Hepatology"},{"key":"1147_CR64","doi-asserted-by":"publisher","first-page":"16871","DOI":"10.1074\/jbc.274.24.16871","volume":"274","author":"X Sun","year":"1999","unstructured":"Sun, X. et al. RIP3, a novel apoptosis-inducing kinase. J. Biol. Chem. 274, 16871\u201316875 (1999).","journal-title":"J. Biol. Chem."},{"key":"1147_CR65","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1038\/s41418-021-00742-x","volume":"28","author":"AL Samson","year":"2021","unstructured":"Samson, A. L. et al. A toolbox for imaging RIPK1, RIPK3, and MLKL in mouse and human cells. Cell Death Differ. 28, 2126\u20132144 (2021).","journal-title":"Cell Death Differ."},{"key":"1147_CR66","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1053\/j.gastro.2022.08.040","volume":"163","author":"SP Preston","year":"2022","unstructured":"Preston, S. P. et al. Epigenetic silencing of RIPK3 in hepatocytes prevents MLKL-mediated necroptosis from contributing to liver pathologies. Gastroenterology 163, 1643\u20131657.e14 (2022).","journal-title":"Gastroenterology"},{"key":"1147_CR67","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05794-0","volume":"14","author":"J Hoff","year":"2023","unstructured":"Hoff, J. et al. RIPK3 promoter hypermethylation in hepatocytes protects from bile acid-induced inflammation and necroptosis. Cell Death Dis. 14, 275 (2023).","journal-title":"Cell Death Dis."},{"key":"1147_CR68","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1038\/cr.2015.56","volume":"25","author":"GB Koo","year":"2015","unstructured":"Koo, G. B. et al. Methylation-dependent loss of RIP3 expression in cancer represses programmed necrosis in response to chemotherapeutics. Cell Res. 25, 707\u2013725 (2015).","journal-title":"Cell Res."},{"key":"1147_CR69","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1016\/j.celrep.2017.05.012","volume":"19","author":"Z Yang","year":"2017","unstructured":"Yang, Z. et al. 2-HG inhibits necroptosis by stimulating DNMT1-dependent hypermethylation of the RIP3 promoter. Cell Rep. 19, 1846\u20131857 (2017).","journal-title":"Cell Rep."},{"key":"1147_CR70","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.483","volume":"8","author":"C Yang","year":"2017","unstructured":"Yang, C. et al. Regulation of RIP3 by the transcription factor Sp1 and the epigenetic regulator UHRF1 modulates cancer cell necroptosis. Cell Death Dis. 8, e3084 (2017).","journal-title":"Cell Death Dis."},{"key":"1147_CR71","doi-asserted-by":"publisher","first-page":"2855","DOI":"10.1002\/eji.200838469","volume":"38","author":"N Despoix","year":"2008","unstructured":"Despoix, N. et al. Mouse CD146\/MCAM is a marker of natural killer cell maturation. Eur. J. Immunol. 38, 2855\u20132864 (2008).","journal-title":"Eur. J. Immunol."},{"key":"1147_CR72","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41423-023-01047-4","volume":"20","author":"L Jing","year":"2023","unstructured":"Jing, L. et al. A subpopulation of CD146+ macrophages enhances antitumor immunity by activating the NLRP3 inflammasome. Cell Mol. Immunol. 20, 908\u2013923 (2023).","journal-title":"Cell Mol. Immunol."},{"key":"1147_CR73","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/nm.2667","volume":"18","author":"L Boulter","year":"2012","unstructured":"Boulter, L. et al. Macrophage-derived wnt opposes notch signaling to specify hepatic progenitor cell fate in chronic liver disease. Nat. Med. 18, 572\u2013579 (2012).","journal-title":"Nat. Med."},{"key":"1147_CR74","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41575-020-0342-4","volume":"18","author":"GK Michalopoulos","year":"2021","unstructured":"Michalopoulos, G. K. & Bhushan, B. Liver regeneration: biological and pathological mechanisms and implications. Nat. Rev. Gastroenterol. Hepatol. 18, 40\u201355 (2021).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"1147_CR75","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.jcmgh.2021.10.009","volume":"13","author":"S Shi","year":"2022","unstructured":"Shi, S. et al. Recapitulating cholangiopathy-associated necroptotic cell death in vitro using human cholangiocyte organoids. Cell Mol. Gastroenterol. Hepatol. 13, 541\u2013564 (2022).","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"1147_CR76","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-35804-w","volume":"14","author":"Y Inaba","year":"2023","unstructured":"Inaba, Y. et al. The transcription factor ATF3 switches cell death from apoptosis to necroptosis in hepatic steatosis in male mice. Nat. Commun. 14, 167 (2023).","journal-title":"Nat. Commun."},{"key":"1147_CR77","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1038\/s42255-022-00700-y","volume":"4","author":"S Gallage","year":"2022","unstructured":"Gallage, S. et al. A researcher\u2019s guide to preclinical mouse NASH models. Nat. Metab. 4, 1632\u20131649 (2022).","journal-title":"Nat. Metab."},{"key":"1147_CR78","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1016\/j.immuni.2023.05.017","volume":"56","author":"M Vucur","year":"2023","unstructured":"Vucur, M. et al. Sublethal necroptosis signaling promotes inflammation and liver cancer. Immunity 56, 1578\u20131595.e8 (2023).","journal-title":"Immunity"},{"key":"1147_CR79","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2015.240","volume":"6","author":"P Geserick","year":"2015","unstructured":"Geserick, P. et al. Absence of RIPK3 predicts necroptosis resistance in malignant melanoma. Cell Death Dis. 6, e1884 (2015).","journal-title":"Cell Death Dis."},{"key":"1147_CR80","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nature13608","volume":"513","author":"M Dannappel","year":"2014","unstructured":"Dannappel, M. et al. RIPK1 maintains epithelial homeostasis by inhibiting apoptosis and necroptosis. Nature 513, 90\u201394 (2014).","journal-title":"Nature"},{"key":"1147_CR81","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.devcel.2021.12.015","volume":"57","author":"W Wang","year":"2022","unstructured":"Wang, W. et al. Sensing plasma membrane pore formation induces chemokine production in survivors of regulated necrosis. Dev. Cell 57, 228\u2013245.e6 (2022).","journal-title":"Dev. Cell"},{"key":"1147_CR82","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.it.2016.06.002","volume":"37","author":"AT Ting","year":"2016","unstructured":"Ting, A. T. & Bertrand, M. J. M. More to life than NF-\u03baB in TNFR1 signaling. Trends Immunol. 37, 535\u2013545 (2016).","journal-title":"Trends Immunol."},{"key":"1147_CR83","doi-asserted-by":"publisher","first-page":"11180","DOI":"10.1096\/fj.201900752R","volume":"33","author":"S Wei","year":"2019","unstructured":"Wei, S. et al. RIP3 deficiency alleviates liver fibrosis by inhibiting ROCK1-TLR4-NF-\u03baB pathway in macrophages. FASEB J. 33, 11180\u201311193 (2019).","journal-title":"FASEB J."},{"key":"1147_CR84","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1038\/s41418-020-00668-w","volume":"28","author":"L Tao","year":"2021","unstructured":"Tao, L. et al. RIP1 kinase activity promotes steatohepatitis through mediating cell death and inflammation in macrophages. Cell Death Differ. 28, 1418\u20131433 (2021).","journal-title":"Cell Death Differ."},{"key":"1147_CR85","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1002\/hep.32612","volume":"77","author":"X Wu","year":"2023","unstructured":"Wu, X. et al. Macrophage-derived MLKL in alcohol-associated liver disease: regulation of phagocytosis. Hepatology 77, 902\u2013919 (2023).","journal-title":"Hepatology"},{"key":"1147_CR86","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241411313","volume":"24","author":"M Yan","year":"2023","unstructured":"Yan, M. et al. Targeting endothelial necroptosis disrupts profibrotic endothelial-hepatic stellate cells crosstalk to alleviate liver fibrosis in nonalcoholic steatohepatitis. Int. J. Mol. Sci. 24, 11313 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"1147_CR87","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1172\/JCI96147","volume":"128","author":"M Zelic","year":"2018","unstructured":"Zelic, M. et al. RIP kinase 1-dependent endothelial necroptosis underlies systemic inflammatory response syndrome. J. Clin. Invest. 128, 2064\u20132075 (2018).","journal-title":"J. Clin. Invest."},{"key":"1147_CR88","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/nature19076","volume":"536","author":"B Strilic","year":"2016","unstructured":"Strilic, B. et al. Tumour-cell-induced endothelial cell necroptosis via death receptor 6 promotes metastasis. Nature 536, 215\u2013218 (2016).","journal-title":"Nature"},{"key":"1147_CR89","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41575-019-0125-y","volume":"16","author":"JM Banales","year":"2019","unstructured":"Banales, J. M. et al. Cholangiocyte pathobiology. Nat. Rev. Gastroenterol. Hepatol. 16, 269\u2013281 (2019).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"1147_CR90","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.jhep.2019.11.024","volume":"72","author":"SA Harrison","year":"2020","unstructured":"Harrison, S. A. et al. A randomized, placebo-controlled trial of emricasan in patients with NASH and F1-F3 fibrosis. J. Hepatol. 72, 816\u2013827 (2020).","journal-title":"J. Hepatol."},{"key":"1147_CR91","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41575-018-0009-6","volume":"15","author":"S Schuster","year":"2018","unstructured":"Schuster, S., Cabrera, D., Arrese, M. & Feldstein, A. E. Triggering and resolution of inflammation in NASH. Nat. Rev. Gastroenterol. Hepatol. 15, 349\u2013364 (2018).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"1147_CR92","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.jhep.2020.07.041","volume":"74","author":"S Gaul","year":"2021","unstructured":"Gaul, S. et al. Hepatocyte pyroptosis and release of inflammasome particles induce stellate cell activation and liver fibrosis. J. Hepatol. 74, 156\u2013167 (2021).","journal-title":"J. Hepatol."},{"key":"1147_CR93","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1007\/s00109-014-1170-1","volume":"92","author":"A Wree","year":"2014","unstructured":"Wree, A. et al. NLRP3 inflammasome activation is required for fibrosis development in NAFLD. J. Mol. Med. 92, 1069\u20131082 (2014).","journal-title":"J. Mol. Med."},{"key":"1147_CR94","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1002\/hep.29645","volume":"67","author":"E Khanova","year":"2018","unstructured":"Khanova, E. et al. Pyroptosis by caspase11\/4-gasdermin-D pathway in alcoholic hepatitis in mice and patients. Hepatology 67, 1737\u20131753 (2018).","journal-title":"Hepatology"},{"key":"1147_CR95","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.jhep.2017.11.040","volume":"68","author":"B Xu","year":"2018","unstructured":"Xu, B. et al. Gasdermin D plays a key role as a pyroptosis executor of non-alcoholic steatohepatitis in humans and mice. J. Hepatol. 68, 773\u2013782 (2018).","journal-title":"J. Hepatol."},{"key":"1147_CR96","doi-asserted-by":"publisher","first-page":"167271","DOI":"10.1016\/j.jmb.2021.167271","volume":"434","author":"J Knorr","year":"2022","unstructured":"Knorr, J., Wree, A. & Feldstein, A. E. Pyroptosis in steatohepatitis and liver diseases. J. Mol. Biol. 434, 167271 (2022).","journal-title":"J. Mol. Biol."},{"key":"1147_CR97","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1016\/j.cmet.2022.09.017","volume":"34","author":"H Tilg","year":"2022","unstructured":"Tilg, H., Adolph, T. E. & Trauner, M. Gut-liver axis: pathophysiological concepts and clinical implications. Cell Metab. 34, 1700\u20131718 (2022).","journal-title":"Cell Metab."},{"key":"1147_CR98","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1194\/jlr.M034876","volume":"54","author":"GN Ioannou","year":"2013","unstructured":"Ioannou, G. N., Haigh, W. G., Thorning, D. & Savard, C. Hepatic cholesterol crystals and crown-like structures distinguish NASH from simple steatosis. J. Lipid Res. 54, 1326\u20131334 (2013).","journal-title":"J. Lipid Res."},{"key":"1147_CR99","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1194\/jlr.M053785","volume":"56","author":"GN Ioannou","year":"2015","unstructured":"Ioannou, G. N. et al. Cholesterol-lowering drugs cause dissolution of cholesterol crystals and disperse Kupffer cell crown-like structures during resolution of NASH. J. Lipid Res. 56, 277\u2013285 (2015).","journal-title":"J. Lipid Res."},{"key":"1147_CR100","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.cellimm.2018.08.006","volume":"332","author":"J Pan","year":"2018","unstructured":"Pan, J. et al. Fatty acid activates NLRP3 inflammasomes in mouse Kupffer cells through mitochondrial DNA release. Cell Immunol. 332, 111\u2013120 (2018).","journal-title":"Cell Immunol."},{"key":"1147_CR101","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/j.jhep.2015.06.013","volume":"63","author":"A Iracheta-Vellve","year":"2015","unstructured":"Iracheta-Vellve, A. et al. Inhibition of sterile danger signals, uric acid and ATP, prevents inflammasome activation and protects from alcoholic steatohepatitis in mice. J. Hepatol. 63, 1147\u20131155 (2015).","journal-title":"J. Hepatol."},{"key":"1147_CR102","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1189\/jlb.3AB1214-590R","volume":"98","author":"J Petrasek","year":"2015","unstructured":"Petrasek, J. et al. Metabolic danger signals, uric acid and ATP, mediate inflammatory cross-talk between hepatocytes and immune cells in alcoholic liver disease. J. Leukoc. Biol. 98, 249\u2013256 (2015).","journal-title":"J. Leukoc. Biol."},{"key":"1147_CR103","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.jcmgh.2021.11.009","volume":"13","author":"P Sun","year":"2022","unstructured":"Sun, P. et al. Hepatocytes are resistant to cell death from canonical and non-canonical inflammasome-activated pyroptosis. Cell Mol. Gastroenterol. Hepatol. 13, 739\u2013757 (2022).","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"1147_CR104","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.jcmgh.2019.12.008","volume":"9","author":"SY Cai","year":"2020","unstructured":"Cai, S. Y. et al. Inflammasome is activated in the liver of cholestatic patients and aggravates hepatic injury in bile duct-ligated mouse. Cell Mol. Gastroenterol. Hepatol. 9, 679\u2013688 (2020).","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"1147_CR105","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/j.immuni.2016.10.009","volume":"45","author":"C Guo","year":"2016","unstructured":"Guo, C. et al. Bile acids control inflammation and metabolic disorder through inhibition of NLRP3 inflammasome. Immunity 45, 944 (2016).","journal-title":"Immunity"},{"key":"1147_CR106","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1002\/hep.31494","volume":"73","author":"M Frissen","year":"2021","unstructured":"Frissen, M. et al. Bidirectional role of NLRP3 during acute and chronic cholestatic liver injury. Hepatology 73, 1836\u20131854 (2021).","journal-title":"Hepatology"},{"key":"1147_CR107","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.intimp.2019.02.016","volume":"70","author":"J Qu","year":"2019","unstructured":"Qu, J., Yuan, Z., Wang, G., Wang, X. & Li, K. The selective NLRP3 inflammasome inhibitor MCC950 alleviates cholestatic liver injury and fibrosis in mice. Int. Immunopharmacol. 70, 147\u2013155 (2019).","journal-title":"Int. Immunopharmacol."},{"key":"1147_CR108","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/s41401-020-0434-2","volume":"42","author":"WF Xu","year":"2021","unstructured":"Xu, W. F. et al. Gasdermin E-derived caspase-3 inhibitors effectively protect mice from acute hepatic failure. Acta Pharmacol. Sin. 42, 68\u201376 (2021).","journal-title":"Acta Pharmacol. Sin."},{"key":"1147_CR109","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nature10809","volume":"482","author":"J Henao-Mejia","year":"2012","unstructured":"Henao-Mejia, J. et al. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature 482, 179\u2013185 (2012).","journal-title":"Nature"},{"key":"1147_CR110","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1055\/s-2006-960172","volume":"27","author":"M Trauner","year":"2007","unstructured":"Trauner, M., Fickert, P. & Wagner, M. MDR3 (ABCB4) defects: a paradigm for the genetics of adult cholestatic syndromes. Semin. Liver Dis. 27, 77\u201398 (2007).","journal-title":"Semin. Liver Dis."},{"key":"1147_CR111","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1136\/gutjnl-2018-316670","volume":"68","author":"L Liao","year":"2019","unstructured":"Liao, L. et al. Intestinal dysbiosis augments liver disease progression via NLRP3 in a murine model of primary sclerosing cholangitis. Gut 68, 1477\u20131492 (2019).","journal-title":"Gut"},{"key":"1147_CR112","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.jcmgh.2022.06.007","volume":"14","author":"B Kaufmann","year":"2022","unstructured":"Kaufmann, B. et al. Cell-specific deletion of NLRP3 inflammasome identifies myeloid cells as key drivers of liver inflammation and fibrosis in murine steatohepatitis. Cell Mol. Gastroenterol. Hepatol. 14, 751\u2013767 (2022).","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"1147_CR113","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202154446","volume":"23","author":"B Kaufmann","year":"2022","unstructured":"Kaufmann, B. et al. NLRP3 activation in neutrophils induces lethal autoinflammation, liver inflammation, and fibrosis. EMBO Rep. 23, e54446 (2022).","journal-title":"EMBO Rep."},{"key":"1147_CR114","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1002\/hep.26592","volume":"59","author":"A Wree","year":"2014","unstructured":"Wree, A. et al. NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice. Hepatology 59, 898\u2013910 (2014).","journal-title":"Hepatology"},{"key":"1147_CR115","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1016\/j.jcmgh.2023.03.002","volume":"15","author":"J Vonderlin","year":"2023","unstructured":"Vonderlin, J., Chavakis, T., Sieweke, M. & Tacke, F. The multifaceted roles of macrophages in NAFLD pathogenesis. Cell Mol. Gastroenterol. Hepatol. 15, 1311\u20131324 (2023).","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"1147_CR116","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/hep4.1801","volume":"6","author":"CL Horn","year":"2022","unstructured":"Horn, C. L., Morales, A. L., Savard, C., Farrell, G. C. & Ioannou, G. N. Role of cholesterol-associated steatohepatitis in the development of NASH. Hepatol. Commun. 6, 12\u201335 (2022).","journal-title":"Hepatol. Commun."},{"key":"1147_CR117","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1038\/nature08938","volume":"464","author":"P Duewell","year":"2010","unstructured":"Duewell, P. et al. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 464, 1357\u20131361 (2010).","journal-title":"Nature"},{"key":"1147_CR118","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/nri3793","volume":"15","author":"AR Tall","year":"2015","unstructured":"Tall, A. R. & Yvan-Charvet, L. Cholesterol, inflammation and innate immunity. Nat. Rev. Immunol. 15, 104\u2013116 (2015).","journal-title":"Nat. Rev. Immunol."},{"key":"1147_CR119","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1038\/s41418-022-01058-0","volume":"30","author":"G Hacker","year":"2023","unstructured":"Hacker, G. & Haimovici, A. Sub-lethal signals in the mitochondrial apoptosis apparatus: pernicious by-product or physiological event? Cell Death Differ. 30, 250\u2013257 (2023).","journal-title":"Cell Death Differ."},{"key":"1147_CR120","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2019102325","volume":"38","author":"JS Riley","year":"2019","unstructured":"Riley, J. S. & Tait, S. W. Mitochondria and pathogen immunity: from killer to firestarter. EMBO J. 38, e102325 (2019).","journal-title":"EMBO J."},{"key":"1147_CR121","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.jhep.2017.01.022","volume":"66","author":"AR Mridha","year":"2017","unstructured":"Mridha, A. R. et al. NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice. J. Hepatol. 66, 1037\u20131046 (2017).","journal-title":"J. Hepatol."},{"key":"1147_CR122","doi-asserted-by":"publisher","first-page":"3476","DOI":"10.1172\/JCI60777","volume":"122","author":"J Petrasek","year":"2012","unstructured":"Petrasek, J. et al. IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice. J. Clin. Invest. 122, 3476\u20133489 (2012).","journal-title":"J. Clin. Invest."},{"key":"1147_CR123","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.cgh.2024.07.025","volume":"23","author":"N Vergis","year":"2025","unstructured":"Vergis, N. et al. IL-1 signal inhibition in alcohol-related hepatitis: a randomized, double-blind, placebo-controlled trial of canakinumab. Clin. Gastroenterol. Hepatol. 23, 797\u2013807.e5 (2025).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"1147_CR124","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.jhep.2024.01.031","volume":"80","author":"S Gawrieh","year":"2024","unstructured":"Gawrieh, S. et al. Randomized trial of anakinra plus zinc vs. prednisone for severe alcohol-associated hepatitis. J. Hepatol. 80, 684\u2013693 (2024).","journal-title":"J. Hepatol."},{"key":"1147_CR125","doi-asserted-by":"publisher","first-page":"175091","DOI":"10.1016\/j.ejphar.2022.175091","volume":"928","author":"H Li","year":"2022","unstructured":"Li, H. et al. Therapeutic potential of MCC950, a specific inhibitor of NLRP3 inflammasome. Eur. J. Pharmacol. 928, 175091 (2022).","journal-title":"Eur. J. Pharmacol."},{"key":"1147_CR126","doi-asserted-by":"publisher","first-page":"102489","DOI":"10.1016\/j.coi.2024.102489","volume":"91","author":"V Nadella","year":"2024","unstructured":"Nadella, V. & Kanneganti, T. D. Inflammasomes and their role in PANoptosomes. Curr. Opin. Immunol. 91, 102489 (2024).","journal-title":"Curr. Opin. Immunol."},{"key":"1147_CR127","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1719-6","volume":"10","author":"C Yang","year":"2019","unstructured":"Yang, C. et al. Gasdermin D protects against noninfectious liver injury by regulating apoptosis and necroptosis. Cell Death Dis. 10, 481 (2019).","journal-title":"Cell Death Dis."},{"key":"1147_CR128","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.redox.2016.05.003","volume":"9","author":"BA Carlson","year":"2016","unstructured":"Carlson, B. A. et al. Glutathione peroxidase 4 and vitamin E cooperatively prevent hepatocellular degeneration. Redox Biol. 9, 22\u201331 (2016).","journal-title":"Redox Biol."},{"key":"1147_CR129","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28718-6","volume":"13","author":"S Van Coillie","year":"2022","unstructured":"Van Coillie, S. et al. Targeting ferroptosis protects against experimental (multi)organ dysfunction and death. Nat. Commun. 13, 1046 (2022).","journal-title":"Nat. Commun."},{"key":"1147_CR130","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1046\/j.1440-1746.2001.02445.x","volume":"16","author":"GA MacDonald","year":"2001","unstructured":"MacDonald, G. A. et al. Lipid peroxidation in hepatic steatosis in humans is associated with hepatic fibrosis and occurs predominately in acinar zone 3. J. Gastroenterol. Hepatol. 16, 599\u2013606 (2001).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"1147_CR131","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/S0168-8278(02)00073-9","volume":"37","author":"S Seki","year":"2002","unstructured":"Seki, S. et al. In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver diseases. J. Hepatol. 37, 56\u201362 (2002).","journal-title":"J. Hepatol."},{"key":"1147_CR132","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.jhep.2008.01.016","volume":"48","author":"N Chalasani","year":"2008","unstructured":"Chalasani, N. et al. Relationship of steatosis grade and zonal location to histological features of steatohepatitis in adult patients with non-alcoholic fatty liver disease. J. Hepatol. 48, 829\u2013834 (2008).","journal-title":"J. Hepatol."},{"key":"1147_CR133","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1038\/s43587-023-00513-y","volume":"3","author":"C Nikopoulou","year":"2023","unstructured":"Nikopoulou, C. et al. Spatial and single-cell profiling of the metabolome, transcriptome and epigenome of the aging mouse liver. Nat. Aging 3, 1430\u20131445 (2023).","journal-title":"Nat. Aging"},{"key":"1147_CR134","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1002\/hep.22268","volume":"47","author":"BK Straub","year":"2008","unstructured":"Straub, B. K., Stoeffel, P., Heid, H., Zimbelmann, R. & Schirmacher, P. Differential pattern of lipid droplet-associated proteins and de novo perilipin expression in hepatocyte steatogenesis. Hepatology 47, 1936\u20131946 (2008).","journal-title":"Hepatology"},{"key":"1147_CR135","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1053\/j.gastro.2014.07.056","volume":"147","author":"MM Yeh","year":"2014","unstructured":"Yeh, M. M. & Brunt, E. M. Pathological features of fatty liver disease. Gastroenterology 147, 754\u2013764 (2014).","journal-title":"Gastroenterology"},{"key":"1147_CR136","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1002\/hep.29117","volume":"66","author":"H Wang","year":"2017","unstructured":"Wang, H. et al. Characterization of ferroptosis in murine models of hemochromatosis. Hepatology 66, 449\u2013465 (2017).","journal-title":"Hepatology"},{"key":"1147_CR137","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1038\/s41586-022-05022-3","volume":"608","author":"E Mishima","year":"2022","unstructured":"Mishima, E. et al. A non-canonical vitamin K cycle is a potent ferroptosis suppressor. Nature 608, 778\u2013783 (2022).","journal-title":"Nature"},{"key":"1147_CR138","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1093\/carcin\/bgs230","volume":"33","author":"BA Carlson","year":"2012","unstructured":"Carlson, B. A. et al. Thioredoxin reductase 1 protects against chemically induced hepatocarcinogenesis via control of cellular redox homeostasis. Carcinogenesis 33, 1806\u20131813 (2012).","journal-title":"Carcinogenesis"},{"key":"1147_CR139","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-025-00843-2","author":"E Mishima","year":"2025","unstructured":"Mishima, E. et al. Recommendations for robust and reproducible research on ferroptosis. Nat. Rev. Mol. Cell Biol. https:\/\/doi.org\/10.1038\/s41580-025-00843-2 (2025).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1147_CR140","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1007\/s12253-015-9946-3","volume":"21","author":"T Lorincz","year":"2015","unstructured":"Lorincz, T., Jemnitz, K., Kardon, T., Mandl, J. & Szarka, A. Ferroptosis is involved in acetaminophen induced cell death. Pathol. Oncol. Res. 21, 1115\u20131121 (2015).","journal-title":"Pathol. Oncol. Res."},{"key":"1147_CR141","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-2334-2","volume":"11","author":"N Yamada","year":"2020","unstructured":"Yamada, N. et al. Ferroptosis driven by radical oxidation of n-6 polyunsaturated fatty acids mediates acetaminophen-induced acute liver failure. Cell Death Dis. 11, 144 (2020).","journal-title":"Cell Death Dis."},{"key":"1147_CR142","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.23791","volume":"38","author":"OB Adelusi","year":"2024","unstructured":"Adelusi, O. B., Etemadi, Y., Akakpo, J. Y., Ramachandran, A. & Jaeschke, H. Effect of ferroptosis inhibitors in a murine model of acetaminophen-induced liver injury. J. Biochem. Mol. Toxicol. 38, e23791 (2024).","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"1147_CR143","doi-asserted-by":"publisher","first-page":"116043","DOI":"10.1016\/j.taap.2022.116043","volume":"445","author":"OB Adelusi","year":"2022","unstructured":"Adelusi, O. B., Ramachandran, A., Lemasters, J. J. & Jaeschke, H. The role of iron in lipid peroxidation and protein nitration during acetaminophen-induced liver injury in mice. Toxicol. Appl. Pharmacol. 445, 116043 (2022).","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"1147_CR144","doi-asserted-by":"publisher","first-page":"105088","DOI":"10.1016\/j.ebiom.2024.105088","volume":"102","author":"C Peleman","year":"2024","unstructured":"Peleman, C., Francque, S. & Berghe, T. V. Emerging role of ferroptosis in metabolic dysfunction-associated steatotic liver disease: revisiting hepatic lipid peroxidation. EBioMedicine 102, 105088 (2024).","journal-title":"EBioMedicine"},{"key":"1147_CR145","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1089\/ars.2014.6098","volume":"22","author":"CM Spickett","year":"2015","unstructured":"Spickett, C. M. & Pitt, A. R. Oxidative lipidomics coming of age: advances in analysis of oxidized phospholipids in physiology and pathology. Antioxid. Redox Signal. 22, 1646\u20131666 (2015).","journal-title":"Antioxid. Redox Signal."},{"key":"1147_CR146","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/s41592-022-01710-0","volume":"20","author":"Z Ni","year":"2023","unstructured":"Ni, Z. et al. Guiding the choice of informatics software and tools for lipidomics research applications. Nat. Methods 20, 193\u2013204 (2023).","journal-title":"Nat. Methods"},{"key":"1147_CR147","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1111\/ajt.15773","volume":"20","author":"N Yamada","year":"2020","unstructured":"Yamada, N. et al. Iron overload as a risk factor for hepatic ischemia-reperfusion injury in liver transplantation: potential role of ferroptosis. Am. J. Transpl. 20, 1606\u20131618 (2020).","journal-title":"Am. J. Transpl."},{"key":"1147_CR148","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1038\/ncb3064","volume":"16","author":"JP Friedmann Angeli","year":"2014","unstructured":"Friedmann Angeli, J. P. et al. Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice. Nat. Cell Biol. 16, 1180\u20131191 (2014).","journal-title":"Nat. Cell Biol."},{"key":"1147_CR149","doi-asserted-by":"publisher","first-page":"3783","DOI":"10.1111\/bph.15518","volume":"178","author":"S Wu","year":"2021","unstructured":"Wu, S. et al. Macrophage extracellular traps aggravate iron overload-related liver ischaemia\/reperfusion injury. Br. J. Pharmacol. 178, 3783\u20133796 (2021).","journal-title":"Br. J. Pharmacol."},{"key":"1147_CR150","doi-asserted-by":"publisher","first-page":"164","DOI":"10.3390\/cancers12010164","volume":"12","author":"CM Bebber","year":"2020","unstructured":"Bebber, C. M., Muller, F., Prieto Clemente, L., Weber, J. & von Karstedt, S. Ferroptosis in cancer cell biology. Cancers 12, 164 (2020).","journal-title":"Cancers"},{"key":"1147_CR151","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1016\/j.jcmgh.2022.02.009","volume":"13","author":"S Huang","year":"2022","unstructured":"Huang, S. et al. Hepatic TGF\u03b2r1 deficiency attenuates lipopolysaccharide\/D-galactosamine-induced acute liver failure through inhibiting GSK3\u03b2-Nrf2-mediated hepatocyte apoptosis and ferroptosis. Cell Mol. Gastroenterol. Hepatol. 13, 1649\u20131672 (2022).","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"1147_CR152","doi-asserted-by":"publisher","first-page":"4505513","DOI":"10.1155\/2022\/4505513","volume":"2022","author":"J Wu","year":"2022","unstructured":"Wu, J. et al. Nrf2-mediated ferroptosis inhibition exerts a protective effect on acute-on-chronic liver failure. Oxid. Med. Cell Longev. 2022, 4505513 (2022).","journal-title":"Oxid. Med. Cell Longev."},{"key":"1147_CR153","doi-asserted-by":"publisher","first-page":"1177542","DOI":"10.3389\/fphar.2023.1177542","volume":"14","author":"C Zhao","year":"2023","unstructured":"Zhao, C., Xiao, C., Feng, S. & Bai, J. Artemisitene alters LPS-induced oxidative stress, inflammation and ferroptosis in liver through Nrf2\/HO-1 and NF-kB pathway. Front. Pharmacol. 14, 1177542 (2023).","journal-title":"Front. Pharmacol."},{"key":"1147_CR154","doi-asserted-by":"publisher","first-page":"55137","DOI":"10.1074\/jbc.M410387200","volume":"279","author":"Q Ran","year":"2004","unstructured":"Ran, Q. et al. Transgenic mice overexpressing glutathione peroxidase 4 are protected against oxidative stress-induced apoptosis. J. Biol. Chem. 279, 55137\u201355146 (2004).","journal-title":"J. Biol. Chem."},{"key":"1147_CR155","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.chom.2018.05.009","volume":"24","author":"R Kang","year":"2018","unstructured":"Kang, R. et al. Lipid peroxidation drives gasdermin D-mediated pyroptosis in lethal polymicrobial sepsis. Cell Host Microbe 24, 97\u2013108.e4 (2018).","journal-title":"Cell Host Microbe"},{"key":"1147_CR156","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1016\/j.ajpath.2022.08.010","volume":"193","author":"N Ali","year":"2023","unstructured":"Ali, N., Ferrao, K. & Mehta, K. J. Liver iron loading in alcohol-associated liver disease. Am. J. Pathol. 193, 1427\u20131439 (2023).","journal-title":"Am. J. Pathol."},{"key":"1147_CR157","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1111\/liv.14096","volume":"39","author":"E Buzzetti","year":"2019","unstructured":"Buzzetti, E. et al. Evaluating the association of serum ferritin and hepatic iron with disease severity in non-alcoholic fatty liver disease. Liver Int. 39, 1325\u20131334 (2019).","journal-title":"Liver Int."},{"key":"1147_CR158","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1002\/hep.24038","volume":"53","author":"JE Nelson","year":"2011","unstructured":"Nelson, J. E. et al. Relationship between the pattern of hepatic iron deposition and histological severity in nonalcoholic fatty liver disease. Hepatology 53, 448\u2013457 (2011).","journal-title":"Hepatology"},{"key":"1147_CR159","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1111\/liv.14428","volume":"40","author":"X Li","year":"2020","unstructured":"Li, X. et al. Targeting ferroptosis alleviates methionine-choline deficient (MCD)-diet induced NASH by suppressing liver lipotoxicity. Liver Int. 40, 1378\u20131394 (2020).","journal-title":"Liver Int."},{"key":"1147_CR160","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1080\/09168451.2020.1763155","volume":"84","author":"CY Liu","year":"2020","unstructured":"Liu, C. Y. et al. Ferroptosis is involved in alcohol-induced cell death in vivo and in vitro. Biosci. Biotechnol. Biochem. 84, 1621\u20131628 (2020).","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"1147_CR161","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/s41420-023-01608-6","volume":"9","author":"J Luo","year":"2023","unstructured":"Luo, J. et al. Ferroptosis contributes to ethanol-induced hepatic cell death via labile iron accumulation and GPx4 inactivation. Cell Death Discov. 9, 311 (2023).","journal-title":"Cell Death Discov."},{"key":"1147_CR162","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ajpath.2019.09.011","volume":"190","author":"J Qi","year":"2020","unstructured":"Qi, J., Kim, J. W., Zhou, Z., Lim, C. W. & Kim, B. Ferroptosis affects the progression of nonalcoholic steatohepatitis via the modulation of lipid peroxidation-mediated cell death in mice. Am. J. Pathol. 190, 68\u201381 (2020).","journal-title":"Am. J. Pathol."},{"key":"1147_CR163","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1038\/s41401-022-01010-5","volume":"44","author":"J Tong","year":"2023","unstructured":"Tong, J. et al. Ferroptosis inhibitor liproxstatin-1 alleviates metabolic dysfunction-associated fatty liver disease in mice: potential involvement of PANoptosis. Acta Pharmacol. Sin. 44, 1014\u20131028 (2023).","journal-title":"Acta Pharmacol. Sin."},{"key":"1147_CR164","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1678-y","volume":"10","author":"S Tsurusaki","year":"2019","unstructured":"Tsurusaki, S. et al. Hepatic ferroptosis plays an important role as the trigger for initiating inflammation in nonalcoholic steatohepatitis. Cell Death Dis. 10, 449 (2019).","journal-title":"Cell Death Dis."},{"key":"1147_CR165","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1021\/acschembio.5b00245","volume":"10","author":"SJ Dixon","year":"2015","unstructured":"Dixon, S. J. et al. Human haploid cell genetics reveals roles for lipid metabolism genes in nonapoptotic cell death. ACS Chem. Biol. 10, 1604\u20131609 (2015).","journal-title":"ACS Chem. Biol."},{"key":"1147_CR166","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nchembio.2239","volume":"13","author":"S Doll","year":"2017","unstructured":"Doll, S. et al. ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition. Nat. Chem. Biol. 13, 91\u201398 (2017).","journal-title":"Nat. Chem. Biol."},{"key":"1147_CR167","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1002\/hep.32148","volume":"75","author":"J Duan","year":"2022","unstructured":"Duan, J. et al. Therapeutic targeting of hepatic ACSL4 ameliorates NASH in mice. Hepatology 75, 140\u2013153 (2022).","journal-title":"Hepatology"},{"key":"1147_CR168","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.2337\/db06-0267","volume":"56","author":"B Askari","year":"2007","unstructured":"Askari, B. et al. Rosiglitazone inhibits acyl-CoA synthetase activity and fatty acid partitioning to diacylglycerol and triacylglycerol via a peroxisome proliferator-activated receptor-\u03b3-independent mechanism in human arterial smooth muscle cells and macrophages. Diabetes 56, 1143\u20131152 (2007).","journal-title":"Diabetes"},{"key":"1147_CR169","doi-asserted-by":"publisher","first-page":"24667","DOI":"10.1074\/jbc.M010793200","volume":"276","author":"JH Kim","year":"2001","unstructured":"Kim, J. H., Lewin, T. M. & Coleman, R. A. Expression and characterization of recombinant rat Acyl-CoA synthetases 1, 4, and 5. Selective inhibition by triacsin C and thiazolidinediones. J. Biol. Chem. 276, 24667\u201324673 (2001).","journal-title":"J. Biol. Chem."},{"key":"1147_CR170","doi-asserted-by":"publisher","first-page":"E880","DOI":"10.1152\/ajpendo.00503.2018","volume":"316","author":"AB Singh","year":"2019","unstructured":"Singh, A. B., Kan, C. F. K., Kraemer, F. B., Sobel, R. A. & Liu, J. Liver-specific knockdown of long-chain acyl-CoA synthetase 4 reveals its key role in VLDL-TG metabolism and phospholipid synthesis in mice fed a high-fat diet. Am. J. Physiol. Endocrinol. Metab. 316, E880\u2013E894 (2019).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"1147_CR171","doi-asserted-by":"publisher","DOI":"10.1097\/HC9.0000000000000684","volume":"9","author":"C Angendohr","year":"2025","unstructured":"Angendohr, C. et al. The ferroptosis mediator ACSL4 fails to prevent disease progression in mouse models of MASLD. Hepatol. Commun. 9, e0684 (2025).","journal-title":"Hepatol. Commun."},{"key":"1147_CR172","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1016\/j.chembiol.2022.06.004","volume":"29","author":"L Magtanong","year":"2022","unstructured":"Magtanong, L. et al. Context-dependent regulation of ferroptosis sensitivity. Cell Chem. Biol. 29, 1409\u20131418.e6 (2022).","journal-title":"Cell Chem. Biol."},{"key":"1147_CR173","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41422-020-00441-1","volume":"31","author":"D Tang","year":"2021","unstructured":"Tang, D., Chen, X., Kang, R. & Kroemer, G. Ferroptosis: molecular mechanisms and health implications. Cell Res. 31, 107\u2013125 (2021).","journal-title":"Cell Res."},{"key":"1147_CR174","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1038\/s41586-023-06191-5","volume":"618","author":"N Kayagaki","year":"2023","unstructured":"Kayagaki, N. et al. Inhibiting membrane rupture with NINJ1 antibodies limits tissue injury. Nature 618, 1072\u20131077 (2023).","journal-title":"Nature"},{"key":"1147_CR175","doi-asserted-by":"publisher","first-page":"5122","DOI":"10.1111\/jcmm.17538","volume":"26","author":"MW Kim","year":"2022","unstructured":"Kim, M. W. et al. Deficiency of ninjurin1 attenuates LPS\/D-galactosamine-induced acute liver failure by reducing TNF-\u03b1-induced apoptosis in hepatocytes. J. Cell Mol. Med. 26, 5122\u20135134 (2022).","journal-title":"J. Cell Mol. Med."},{"key":"1147_CR176","doi-asserted-by":"publisher","first-page":"122782","DOI":"10.1016\/j.lfs.2024.122782","volume":"350","author":"SY Park","year":"2024","unstructured":"Park, S. Y. et al. Loss of ninjurin1 alleviates acetaminophen-induced liver injury via enhancing AMPK\u03b1-NRF2 pathway. Life Sci. 350, 122782 (2024).","journal-title":"Life Sci."},{"key":"1147_CR177","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/j.jcmgh.2023.01.008","volume":"15","author":"Y Hu","year":"2023","unstructured":"Hu, Y. et al. The Ninj1\/Dusp1 axis contributes to liver ischemia reperfusion injury by regulating macrophage activation and neutrophil infiltration. Cell Mol. Gastroenterol. Hepatol. 15, 1071\u20131084 (2023).","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"1147_CR178","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","volume":"7","author":"JM Llovet","year":"2021","unstructured":"Llovet, J. M. et al. Hepatocellular carcinoma. Nat. Rev. Dis. Prim. 7, 6 (2021).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"1147_CR179","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.jhep.2023.02.033","volume":"79","author":"N Yahoo","year":"2023","unstructured":"Yahoo, N., Dudek, M., Knolle, P. & Heikenwalder, M. Role of immune responses in the development of NAFLD-associated liver cancer and prospects for therapeutic modulation. J. Hepatol. 79, 538\u2013551 (2023).","journal-title":"J. Hepatol."},{"key":"1147_CR180","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1056\/NEJMoa1915745","volume":"382","author":"RS Finn","year":"2020","unstructured":"Finn, R. S. et al. Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma. N. Engl. J. Med. 382, 1894\u20131905 (2020).","journal-title":"N. Engl. J. Med."},{"key":"1147_CR181","doi-asserted-by":"publisher","first-page":"EVIDoa2100070","DOI":"10.1056\/EVIDoa2100070","volume":"1","author":"GK Abou-Alfa","year":"2022","unstructured":"Abou-Alfa, G. K. et al. Tremelimumab plus durvalumab in unresectable hepatocellular carcinoma. NEJM Evid. 1, EVIDoa2100070 (2022).","journal-title":"NEJM Evid."},{"key":"1147_CR182","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1158\/1541-7786.MCR-22-0820","volume":"21","author":"S Mohammed","year":"2023","unstructured":"Mohammed, S. et al. Absence of either Ripk3 or mlkl reduces incidence of hepatocellular carcinoma independent of liver fibrosis. Mol. Cancer Res. 21, 933\u2013946 (2023).","journal-title":"Mol. Cancer Res."},{"key":"1147_CR183","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1136\/gutjnl-2020-321767","volume":"70","author":"MB Afonso","year":"2021","unstructured":"Afonso, M. B. et al. RIPK3 acts as a lipid metabolism regulator contributing to inflammation and carcinogenesis in non-alcoholic fatty liver disease. Gut 70, 2359\u20132372 (2021).","journal-title":"Gut"},{"key":"1147_CR184","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/nature17403","volume":"532","author":"L Seifert","year":"2016","unstructured":"Seifert, L. et al. The necrosome promotes pancreatic oncogenesis via CXCL1 and Mincle-induced immune suppression. Nature 532, 245\u2013249 (2016).","journal-title":"Nature"},{"key":"1147_CR185","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-56493-7","volume":"16","author":"AT Schneider","year":"2025","unstructured":"Schneider, A. T. et al. A decision point between transdifferentiation and programmed cell death priming controls KRAS-dependent pancreatic cancer development. Nat. Commun. 16, 1765 (2025).","journal-title":"Nat. Commun."},{"key":"1147_CR186","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ccell.2016.06.002","volume":"30","author":"U Hockendorf","year":"2016","unstructured":"Hockendorf, U. et al. RIPK3 restricts myeloid leukemogenesis by promoting cell death and differentiation of leukemia initiating cells. Cancer Cell 30, 75\u201391 (2016).","journal-title":"Cancer Cell"},{"key":"1147_CR187","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41421-022-00504-0","volume":"9","author":"X Jiang","year":"2023","unstructured":"Jiang, X. et al. A RIPK3-independent role of MLKL in suppressing parthanatos promotes immune evasion in hepatocellular carcinoma. Cell Discov. 9, 7 (2023).","journal-title":"Cell Discov."},{"key":"1147_CR188","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41586-018-0519-y","volume":"562","author":"M Seehawer","year":"2018","unstructured":"Seehawer, M. et al. Necroptosis microenvironment directs lineage commitment in liver cancer. Nature 562, 69\u201375 (2018).","journal-title":"Nature"},{"key":"1147_CR189","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abl7209","volume":"7","author":"R Yamagishi","year":"2022","unstructured":"Yamagishi, R. et al. Gasdermin D-mediated release of IL-33 from senescent hepatic stellate cells promotes obesity-associated hepatocellular carcinoma. Sci. Immunol. 7, eabl7209 (2022).","journal-title":"Sci. Immunol."},{"key":"1147_CR190","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-004763","volume":"10","author":"T Lv","year":"2022","unstructured":"Lv, T. et al. Targeting of GSDMD sensitizes HCC to anti-PD-1 by activating cGAS pathway and downregulating PD-L1 expression. J. Immunother. Cancer 10, e004763 (2022).","journal-title":"J. Immunother. Cancer"},{"key":"1147_CR191","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1126\/science.abb9818","volume":"369","author":"F Humphries","year":"2020","unstructured":"Humphries, F. et al. Succination inactivates gasdermin D and blocks pyroptosis. Science 369, 1633\u20131637 (2020).","journal-title":"Science"},{"key":"1147_CR192","doi-asserted-by":"publisher","first-page":"1264842","DOI":"10.3389\/fphar.2023.1264842","volume":"14","author":"G Bresciani","year":"2023","unstructured":"Bresciani, G. et al. Novel potential pharmacological applications of dimethyl fumarate \u2014 an overview and update. Front. Pharmacol. 14, 1264842 (2023).","journal-title":"Front. Pharmacol."},{"key":"1147_CR193","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.ccell.2019.04.002","volume":"35","author":"B Hassannia","year":"2019","unstructured":"Hassannia, B., Vandenabeele, P. & Vanden Berghe, T. Targeting ferroptosis to iron out cancer. Cancer Cell 35, 830\u2013849 (2019).","journal-title":"Cancer Cell"},{"key":"1147_CR194","doi-asserted-by":"publisher","first-page":"7810","DOI":"10.1111\/febs.16208","volume":"289","author":"K Hino","year":"2022","unstructured":"Hino, K., Yanatori, I., Hara, Y. & Nishina, S. Iron and liver cancer: an inseparable connection. FEBS J. 289, 7810\u20137829 (2022).","journal-title":"FEBS J."},{"key":"1147_CR195","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1002\/hep.28574","volume":"64","author":"X Sun","year":"2016","unstructured":"Sun, X. et al. Metallothionein-1G facilitates sorafenib resistance through inhibition of ferroptosis. Hepatology 64, 488\u2013500 (2016).","journal-title":"Hepatology"},{"key":"1147_CR196","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.70078","volume":"240","author":"HH Tang","year":"2025","unstructured":"Tang, H. H. et al. Targeting GPX4 to overcome sorafenib resistance of human hepatocellular carcinoma by inducing ferroptosis. J. Cell Physiol. 240, e70078 (2025).","journal-title":"J. Cell Physiol."},{"key":"1147_CR197","doi-asserted-by":"publisher","first-page":"101296","DOI":"10.1016\/j.jhepr.2024.101296","volume":"7","author":"ME Delgado","year":"2025","unstructured":"Delgado, M. E. et al. CPEB4 modulates liver cancer progression by translationally regulating hepcidin expression and sensitivity to ferroptosis. JHEP Rep. 7, 101296 (2025).","journal-title":"JHEP Rep."},{"key":"1147_CR198","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1136\/gutjnl-2022-327909","volume":"72","author":"C Conche","year":"2023","unstructured":"Conche, C. et al. Combining ferroptosis induction with MDSC blockade renders primary tumours and metastases in liver sensitive to immune checkpoint blockade. Gut 72, 1774\u20131782 (2023).","journal-title":"Gut"},{"key":"1147_CR199","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jcmgh.2023.03.001","volume":"16","author":"JW Cheu","year":"2023","unstructured":"Cheu, J. W. et al. Ferroptosis suppressor protein 1 inhibition promotes tumor ferroptosis and anti-tumor immune responses in liver cancer. Cell Mol. Gastroenterol. Hepatol. 16, 133\u2013159 (2023).","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"1147_CR200","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3390\/cancers12010077","volume":"12","author":"M Hilmi","year":"2019","unstructured":"Hilmi, M., Vienot, A., Rousseau, B. & Neuzillet, C. Immune therapy for liver cancers. Cancers 12, 77 (2019).","journal-title":"Cancers"},{"key":"1147_CR201","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.it.2022.04.010","volume":"43","author":"J Zhang","year":"2022","unstructured":"Zhang, J., Huang, D., Saw, P. E. & Song, E. Turning cold tumors hot: from molecular mechanisms to clinical applications. Trends Immunol. 43, 523\u2013545 (2022).","journal-title":"Trends Immunol."},{"key":"1147_CR202","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1158\/2159-8290.CD-20-0805","volume":"11","author":"SR Rosenbaum","year":"2021","unstructured":"Rosenbaum, S. R., Wilski, N. A. & Aplin, A. E. Fueling the fire: inflammatory forms of cell death and implications for cancer immunotherapy. Cancer Discov. 11, 266\u2013281 (2021).","journal-title":"Cancer Discov."},{"key":"1147_CR203","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.3390\/cells11091495","volume":"11","author":"JM Gullett","year":"2022","unstructured":"Gullett, J. M., Tweedell, R. E. & Kanneganti, T. D. It\u2019s all in the PAN: crosstalk, plasticity, redundancies, switches, and interconnectedness encompassed by PANoptosis underlying the totality of cell death-associated biological effects. Cells 11, 1495 (2022).","journal-title":"Cells"},{"key":"1147_CR204","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/82732","volume":"1","author":"N Holler","year":"2000","unstructured":"Holler, N. et al. Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nat. Immunol. 1, 489\u2013495 (2000).","journal-title":"Nat. Immunol."},{"key":"1147_CR205","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms8515","volume":"6","author":"S Kang","year":"2015","unstructured":"Kang, S. et al. Caspase-8 scaffolding function and MLKL regulate NLRP3 inflammasome activation downstream of TLR3. Nat. Commun. 6, 7515 (2015).","journal-title":"Nat. Commun."},{"key":"1147_CR206","doi-asserted-by":"publisher","first-page":"E961","DOI":"10.1073\/pnas.1613305114","volume":"114","author":"SA Conos","year":"2017","unstructured":"Conos, S. A. et al. Active MLKL triggers the NLRP3 inflammasome in a cell-intrinsic manner. Proc. Natl Acad. Sci. USA 114, E961\u2013E969 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1147_CR207","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.4049\/jimmunol.1601757","volume":"198","author":"KD Gutierrez","year":"2017","unstructured":"Gutierrez, K. D. et al. MLKL activation triggers NLRP3-mediated processing and release of IL-1\u03b2 independently of gasdermin-D. J. Immunol. 198, 2156\u20132164 (2017).","journal-title":"J. Immunol."},{"key":"1147_CR208","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09397-2","volume":"10","author":"C Rogers","year":"2019","unstructured":"Rogers, C. et al. Gasdermin pores permeabilize mitochondria to augment caspase-3 activation during apoptosis and inflammasome activation. Nat. Commun. 10, 1689 (2019).","journal-title":"Nat. Commun."},{"key":"1147_CR209","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abc3465","volume":"6","author":"B Demarco","year":"2020","unstructured":"Demarco, B. et al. Caspase-8-dependent gasdermin D cleavage promotes antimicrobial defense but confers susceptibility to TNF-induced lethality. Sci. Adv. 6, eabc3465 (2020).","journal-title":"Sci. Adv."},{"key":"1147_CR210","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.4049\/jimmunol.2100757","volume":"207","author":"Y Wang","year":"2021","unstructured":"Wang, Y. et al. Cutting edge: caspase-8 is a linchpin in caspase-3 and gasdermin D activation to control cell death, cytokine release, and host defense during influenza A virus infection. J. Immunol. 207, 2411\u20132416 (2021).","journal-title":"J. Immunol."},{"key":"1147_CR211","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1056\/NEJMra0901217","volume":"361","author":"RS Hotchkiss","year":"2009","unstructured":"Hotchkiss, R. S., Strasser, A., McDunn, J. E. & Swanson, P. E. Cell death. N. Engl. J. Med. 361, 1570\u20131583 (2009).","journal-title":"N. Engl. J. Med."},{"key":"1147_CR212","doi-asserted-by":"publisher","first-page":"102243","DOI":"10.1016\/j.nano.2020.102243","volume":"29","author":"MR Sepand","year":"2020","unstructured":"Sepand, M. R. et al. Targeting non-apoptotic cell death in cancer treatment by nanomaterials: recent advances and future outlook. Nanomedicine 29, 102243 (2020).","journal-title":"Nanomedicine"},{"key":"1147_CR213","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3390\/pharmaceutics14010041","volume":"14","author":"A Bakrania","year":"2021","unstructured":"Bakrania, A., Zheng, G. & Bhat, M. Nanomedicine in hepatocellular carcinoma: a new frontier in targeted cancer treatment. Pharmaceutics 14, 41 (2021).","journal-title":"Pharmaceutics"},{"key":"1147_CR214","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.addr.2020.06.017","volume":"154-155","author":"R Bottger","year":"2020","unstructured":"Bottger, R. et al. Lipid-based nanoparticle technologies for liver targeting. Adv. Drug Deliv. Rev. 154-155, 79\u2013101 (2020).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"1147_CR215","doi-asserted-by":"publisher","first-page":"771","DOI":"10.3390\/jpm11080771","volume":"11","author":"J Wu","year":"2021","unstructured":"Wu, J. The enhanced permeability and retention (EPR) effect: the significance of the concept and methods to enhance its application. J. Pers. Med 11, 771 (2021).","journal-title":"J. Pers. Med"},{"key":"1147_CR216","doi-asserted-by":"publisher","first-page":"188621","DOI":"10.1016\/j.bbcan.2021.188621","volume":"1876","author":"KJ Mintz","year":"2021","unstructured":"Mintz, K. J. & Leblanc, R. M. The use of nanotechnology to combat liver cancer: progress and perspectives. Biochim. Biophys. Acta Rev. Cancer 1876, 188621 (2021).","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"1147_CR217","doi-asserted-by":"publisher","first-page":"947208","DOI":"10.3389\/fmolb.2022.947208","volume":"9","author":"L Li","year":"2022","unstructured":"Li, L., Wang, X., Xu, H., Liu, X. & Xu, K. Perspectives and mechanisms for targeting ferroptosis in the treatment of hepatocellular carcinoma. Front. Mol. Biosci. 9, 947208 (2022).","journal-title":"Front. Mol. Biosci."},{"key":"1147_CR218","first-page":"30","volume":"33","author":"J Liu","year":"2024","unstructured":"Liu, J., Chen, T., Liu, X., Li, Z. & Zhang, Y. Engineering materials for pyroptosis induction in cancer treatment. Bioact. Mater. 33, 30\u201345 (2024).","journal-title":"Bioact. Mater."},{"key":"1147_CR219","doi-asserted-by":"publisher","first-page":"4378","DOI":"10.1039\/D3NR06059D","volume":"16","author":"J Zhong","year":"2024","unstructured":"Zhong, J., Zhao, R., Wang, Y., Su, Y. X. & Lan, X. Nano-PROTACs: state of the art and perspectives. Nanoscale 16, 4378\u20134391 (2024).","journal-title":"Nanoscale"},{"key":"1147_CR220","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/s41392-022-00966-4","volume":"7","author":"L Zhao","year":"2022","unstructured":"Zhao, L., Zhao, J., Zhong, K., Tong, A. & Jia, D. Targeted protein degradation: mechanisms, strategies and application. Signal. Transduct. Target. Ther. 7, 113 (2022).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"1147_CR221","doi-asserted-by":"publisher","first-page":"149125","DOI":"10.1016\/j.bbrc.2023.149125","volume":"684","author":"F Niu","year":"2023","unstructured":"Niu, F. et al. A GPX4 non-enzymatic domain and MDM2 targeting peptide PROTAC for acute lymphoid leukemia therapy through ferroptosis induction. Biochem. Biophys. Res. Commun. 684, 149125 (2023).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"1147_CR222","doi-asserted-by":"publisher","first-page":"117352","DOI":"10.1016\/j.bmc.2023.117352","volume":"90","author":"M Cai","year":"2023","unstructured":"Cai, M. et al. Design and synthesis of proteolysis-targeting chimeras (PROTACs) as degraders of glutathione peroxidase 4. Bioorg. Med. Chem. 90, 117352 (2023).","journal-title":"Bioorg. Med. Chem."},{"key":"1147_CR223","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202313460","volume":"36","author":"D Huang","year":"2024","unstructured":"Huang, D. et al. A PROTAC augmenter for photo-driven pyroptosis in breast cancer. Adv. Mater. 36, e2313460 (2024).","journal-title":"Adv. Mater."},{"key":"1147_CR224","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.7150\/thno.92526","volume":"14","author":"XJ Dai","year":"2024","unstructured":"Dai, X. J. et al. Degraders in epigenetic therapy: PROTACs and beyond. Theranostics 14, 1464\u20131499 (2024).","journal-title":"Theranostics"},{"key":"1147_CR225","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1089\/nat.2018.0736","volume":"28","author":"AD Springer","year":"2018","unstructured":"Springer, A. D. & Dowdy, S. F. GalNAc-siRNA conjugates: leading the way for delivery of RNAi therapeutics. Nucleic Acid. Ther. 28, 109\u2013118 (2018).","journal-title":"Nucleic Acid. Ther."},{"key":"1147_CR226","doi-asserted-by":"publisher","first-page":"12388","DOI":"10.1093\/nar\/gkx960","volume":"45","author":"M Tanowitz","year":"2017","unstructured":"Tanowitz, M. et al. Asialoglycoprotein receptor 1 mediates productive uptake of N-acetylgalactosamine-conjugated and unconjugated phosphorothioate antisense oligonucleotides into liver hepatocytes. Nucleic Acids Res. 45, 12388\u201312400 (2017).","journal-title":"Nucleic Acids Res."},{"key":"1147_CR227","doi-asserted-by":"publisher","first-page":"22240","DOI":"10.1021\/acsnano.3c01199","volume":"17","author":"Y Gao","year":"2023","unstructured":"Gao, Y. et al. Long noncoding RNA URB1-antisense RNA 1 (AS1) suppresses sorafenib-induced ferroptosis in hepatocellular carcinoma by driving ferritin phase separation. ACS Nano 17, 22240\u201322258 (2023).","journal-title":"ACS Nano"},{"key":"1147_CR228","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06535-7","volume":"15","author":"L Shojaie","year":"2024","unstructured":"Shojaie, L. et al. Innate and adaptive immune cell interaction drives inflammasome activation and hepatocyte apoptosis in murine liver injury from immune checkpoint inhibitors. Cell Death Dis. 15, 140 (2024).","journal-title":"Cell Death Dis."},{"key":"1147_CR229","doi-asserted-by":"publisher","first-page":"7380","DOI":"10.1021\/jacs.1c00451","volume":"143","author":"J Liu","year":"2021","unstructured":"Liu, J. et al. Cancer selective target degradation by folate-caged PROTACs. J. Am. Chem. Soc. 143, 7380\u20137387 (2021).","journal-title":"J. Am. Chem. Soc."},{"key":"1147_CR230","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1002\/hep.32733","volume":"77","author":"N Meumann","year":"2023","unstructured":"Meumann, N. et al. Adeno-associated virus serotype 2 capsid variants for improved liver-directed gene therapy. Hepatology 77, 802\u2013815 (2023).","journal-title":"Hepatology"},{"key":"1147_CR231","doi-asserted-by":"publisher","first-page":"427","DOI":"10.3390\/cancers14020427","volume":"14","author":"N Meumann","year":"2022","unstructured":"Meumann, N. et al. Hepatocellular carcinoma is a natural target for adeno-associated virus (AAV) 2 vectors. Cancers 14, 427 (2022).","journal-title":"Cancers"},{"key":"1147_CR232","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202300379","volume":"62","author":"F Zeng","year":"2023","unstructured":"Zeng, F. et al. Ferroptosis detection: from approaches to applications. Angew. Chem. Int. Ed. Engl. 62, e202300379 (2023).","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"1147_CR233","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/978-1-0716-1162-3_13","volume":"2255","author":"Y Feng","year":"2021","unstructured":"Feng, Y. & Huang, X. Methodology for comprehensive detection of pyroptosis. Methods Mol. Biol. 2255, 149\u2013157 (2021).","journal-title":"Methods Mol. Biol."},{"key":"1147_CR234","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.jhep.2023.12.023","volume":"80","author":"TS Andrews","year":"2024","unstructured":"Andrews, T. S. et al. Single-cell, single-nucleus, and spatial transcriptomics characterization of the immunological landscape in the healthy and PSC human liver. J. Hepatol. 80, 730\u2013743 (2024).","journal-title":"J. Hepatol."},{"key":"1147_CR235","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/s41556-023-01316-4","volume":"26","author":"C Bravo Gonzalez-Blas","year":"2024","unstructured":"Bravo Gonzalez-Blas, C. et al. Single-cell spatial multi-omics and deep learning dissect enhancer-driven gene regulatory networks in liver zonation. Nat. Cell Biol. 26, 153\u2013167 (2024).","journal-title":"Nat. Cell Biol."},{"key":"1147_CR236","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1097\/HEP.0000000000000270","volume":"78","author":"A Guillot","year":"2023","unstructured":"Guillot, A. et al. Mapping the hepatic immune landscape identifies monocytic macrophages as key drivers of steatohepatitis and cholangiopathy progression. Hepatology 78, 150\u2013166 (2023).","journal-title":"Hepatology"},{"key":"1147_CR237","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-025-09183-9","author":"AM Dowbaj","year":"2025","unstructured":"Dowbaj, A. M. et al. Mouse liver assembloids model periportal architecture and biliary fibrosis. Nature https:\/\/doi.org\/10.1038\/s41586-025-09183-9 (2025).","journal-title":"Nature"},{"key":"1147_CR238","doi-asserted-by":"publisher","first-page":"103111","DOI":"10.1016\/j.xpro.2024.103111","volume":"5","author":"HY Kim","year":"2024","unstructured":"Kim, H. Y. et al. Protocol to generate human liver spheroids to study liver fibrosis induced by metabolic stress. Star. Protoc. 5, 103111 (2024).","journal-title":"Star. Protoc."},{"key":"1147_CR239","doi-asserted-by":"publisher","first-page":"100465","DOI":"10.1016\/j.jhepr.2022.100465","volume":"4","author":"M Brugger","year":"2022","unstructured":"Brugger, M. et al. High precision-cut liver slice model to study cell-autonomous antiviral defense of hepatocytes within their microenvironment. JHEP Rep. 4, 100465 (2022).","journal-title":"JHEP Rep."},{"key":"1147_CR240","doi-asserted-by":"publisher","first-page":"862185","DOI":"10.3389\/fmed.2022.862185","volume":"9","author":"L Dewyse","year":"2022","unstructured":"Dewyse, L. et al. Improved precision-cut liver slice cultures for testing drug-induced liver fibrosis. Front. Med. 9, 862185 (2022).","journal-title":"Front. Med."},{"key":"1147_CR241","doi-asserted-by":"publisher","first-page":"150","DOI":"10.3390\/ijms25010150","volume":"25","author":"U Rastovic","year":"2023","unstructured":"Rastovic, U. et al. Human precision-cut liver slices: a potential platform to study alcohol-related liver disease. Int J. Mol. Sci. 25, 150 (2023).","journal-title":"Int J. Mol. Sci."},{"key":"1147_CR242","doi-asserted-by":"publisher","DOI":"10.1097\/HC9.0000000000000558","volume":"8","author":"Y Wang","year":"2024","unstructured":"Wang, Y. et al. Precision-cut liver slices as an ex vivo model to evaluate antifibrotic therapies for liver fibrosis and cirrhosis. Hepatol. Commun. 8, e0558 (2024).","journal-title":"Hepatol. Commun."},{"key":"1147_CR243","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1007\/s00204-013-1078-5","volume":"87","author":"P Godoy","year":"2013","unstructured":"Godoy, P. et al. Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME. Arch. Toxicol. 87, 1315\u20131530 (2013).","journal-title":"Arch. Toxicol."},{"key":"1147_CR244","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3390\/bioengineering10020131","volume":"10","author":"I Kaur","year":"2023","unstructured":"Kaur, I. et al. Primary hepatocyte isolation and cultures: technical aspects, challenges and advancements. Bioengineering 10, 131 (2023).","journal-title":"Bioengineering"},{"key":"1147_CR245","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.14309\/ajg.0000000000000912","volume":"115","author":"SR Atkinson","year":"2020","unstructured":"Atkinson, S. R. et al. In severe alcoholic hepatitis, serum keratin-18 fragments are diagnostic, prognostic, and theragnostic biomarkers. Am. J. Gastroenterol. 115, 1857\u20131868 (2020).","journal-title":"Am. J. Gastroenterol."},{"key":"1147_CR246","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1016\/j.cgh.2019.11.050","volume":"18","author":"V Vatsalya","year":"2020","unstructured":"Vatsalya, V. et al. Keratin 18 is a diagnostic and prognostic factor for acute alcoholic hepatitis. Clin. Gastroenterol. Hepatol. 18, 2046\u20132054 (2020).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"1147_CR247","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jhep.2013.07.042","volume":"60","author":"K Cusi","year":"2014","unstructured":"Cusi, K. et al. Limited value of plasma cytokeratin-18 as a biomarker for NASH and fibrosis in patients with non-alcoholic fatty liver disease. J. Hepatol. 60, 167\u2013174 (2014).","journal-title":"J. Hepatol."},{"key":"1147_CR248","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1002\/hep.23050","volume":"50","author":"AE Feldstein","year":"2009","unstructured":"Feldstein, A. E. et al. Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study. Hepatology 50, 1072\u20131078 (2009).","journal-title":"Hepatology"},{"key":"1147_CR249","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0238717","volume":"15","author":"J Lee","year":"2020","unstructured":"Lee, J. et al. Accuracy of cytokeratin 18 (M30 and M65) in detecting non-alcoholic steatohepatitis and fibrosis: a systematic review and meta-analysis. PLoS One 15, e0238717 (2020).","journal-title":"PLoS One"},{"key":"1147_CR250","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s41181-024-00291-x","volume":"9","author":"L Lauwerys","year":"2024","unstructured":"Lauwerys, L. et al. Development of caspase-3-selective activity-based probes for PET imaging of apoptosis. EJNMMI Radiopharm. Chem. 9, 58 (2024).","journal-title":"EJNMMI Radiopharm. Chem."},{"key":"1147_CR251","doi-asserted-by":"publisher","first-page":"15420","DOI":"10.1021\/acs.jmedchem.1c01477","volume":"64","author":"Y Lan","year":"2021","unstructured":"Lan, Y. et al. Visualization of receptor-interacting protein kinase 1 (RIPK1) by brain imaging with positron emission tomography. J. Med. Chem. 64, 15420\u201315428 (2021).","journal-title":"J. Med. Chem."},{"key":"1147_CR252","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1038\/s41571-023-00816-4","volume":"20","author":"TF Greten","year":"2023","unstructured":"Greten, T. F. et al. Biomarkers for immunotherapy of hepatocellular carcinoma. Nat. Rev. Clin. Oncol. 20, 780\u2013798 (2023).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"1147_CR253","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/j.jcmgh.2021.12.006","volume":"13","author":"ME Guicciardi","year":"2022","unstructured":"Guicciardi, M. E. & Gores, G. J. Burning, but not dying: the failure of pyroptotic cell death in hepatocytes. Cell Mol. Gastroenterol. Hepatol. 13, 974\u2013976 (2022).","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"1147_CR254","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.cgh.2018.06.012","volume":"17","author":"CT Frenette","year":"2019","unstructured":"Frenette, C. T. et al. Emricasan improves liver function in patients with cirrhosis and high model for end-stage liver disease scores compared with placebo. Clin. Gastroenterol. Hepatol. 17, 774\u2013783.e4 (2019).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"1147_CR255","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1097\/COC.0000000000000099","volume":"39","author":"FA Lee","year":"2016","unstructured":"Lee, F. A. et al. Randomized phase II study of the X-linked inhibitor of apoptosis (XIAP) antisense AEG35156 in combination with sorafenib in patients with advanced hepatocellular carcinoma (HCC). Am. J. Clin. Oncol. 39, 609\u2013613 (2016).","journal-title":"Am. J. Clin. Oncol."},{"key":"1147_CR256","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1002\/hep.26547","volume":"58","author":"A Ramachandran","year":"2013","unstructured":"Ramachandran, A. et al. Receptor interacting protein kinase 3 is a critical early mediator of acetaminophen-induced hepatocyte necrosis in mice. Hepatology 58, 2099\u20132108 (2013).","journal-title":"Hepatology"},{"key":"1147_CR257","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9371","volume":"6","author":"YJ Kang","year":"2015","unstructured":"Kang, Y. J. et al. Regulation of NKT cell-mediated immune responses to tumours and liver inflammation by mitochondrial PGAM5-Drp1 signalling. Nat. Commun. 6, 8371 (2015).","journal-title":"Nat. Commun."},{"key":"1147_CR258","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.celrep.2013.08.045","volume":"5","author":"R Weinlich","year":"2013","unstructured":"Weinlich, R. et al. Protective roles for caspase-8 and cFLIP in adult homeostasis. Cell Rep. 5, 340\u2013348 (2013).","journal-title":"Cell Rep."},{"key":"1147_CR259","doi-asserted-by":"publisher","first-page":"199","DOI":"10.7150\/ijbs.65402","volume":"18","author":"M Liu","year":"2022","unstructured":"Liu, M. et al. RIP3 blockade prevents immune-mediated hepatitis through a myeloid-derived suppressor cell dependent mechanism. Int. J. Biol. Sci. 18, 199\u2013213 (2022).","journal-title":"Int. J. Biol. Sci."},{"key":"1147_CR260","doi-asserted-by":"publisher","first-page":"5477","DOI":"10.3748\/wjg.v24.i48.5477","volume":"24","author":"WK Saeed","year":"2018","unstructured":"Saeed, W. K. et al. Mismatched effects of receptor interacting protein kinase-3 on hepatic steatosis and inflammation in non-alcoholic fatty liver disease. World J. Gastroenterol. 24, 5477\u20135490 (2018).","journal-title":"World J. Gastroenterol."},{"key":"1147_CR261","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.freeradbiomed.2018.12.034","volume":"134","author":"G Chenxu","year":"2019","unstructured":"Chenxu, G. et al. Loss of RIP3 initiates annihilation of high-fat diet initialized nonalcoholic hepatosteatosis: a mechanism involving toll-like receptor 4 and oxidative stress. Free Radic. Biol. Med. 134, 23\u201341 (2019).","journal-title":"Free Radic. Biol. Med."},{"key":"1147_CR262","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1111\/jgh.14740","volume":"34","author":"WK Saeed","year":"2019","unstructured":"Saeed, W. K. et al. Decrease in fat de novo synthesis and chemokine ligand expression in non-alcoholic fatty liver disease caused by inhibition of mixed lineage kinase domain-like pseudokinase. J. Gastroenterol. Hepatol. 34, 2206\u20132218 (2019).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"1147_CR263","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.molmet.2019.02.003","volume":"23","author":"H Xu","year":"2019","unstructured":"Xu, H. et al. The pseudokinase MLKL regulates hepatic insulin sensitivity independently of inflammation. Mol. Metab. 23, 14\u201323 (2019).","journal-title":"Mol. Metab."},{"key":"1147_CR264","doi-asserted-by":"publisher","first-page":"1267996","DOI":"10.3389\/fendo.2023.1267996","volume":"14","author":"X Wu","year":"2023","unstructured":"Wu, X., Arya, R. K., Huang, E., McMullen, M. R. & Nagy, L. E. Receptor-interacting protein 1 and 3 kinase activity are required for high-fat diet induced liver injury in mice. Front. Endocrinol. 14, 1267996 (2023).","journal-title":"Front. Endocrinol."},{"key":"1147_CR265","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.jhep.2020.03.023","volume":"73","author":"X Wu","year":"2020","unstructured":"Wu, X. et al. MLKL-dependent signaling regulates autophagic flux in a murine model of non-alcohol-associated fatty liver and steatohepatitis. J. Hepatol. 73, 616\u2013627 (2020).","journal-title":"J. Hepatol."},{"key":"1147_CR266","doi-asserted-by":"publisher","first-page":"2813","DOI":"10.3390\/ijms25052813","volume":"25","author":"P Ohene-Marfo","year":"2024","unstructured":"Ohene-Marfo, P. et al. Non-necroptotic roles of MLKL in diet-induced obesity, liver pathology, and insulin sensitivity: insights from a high-fat, high-fructose, high-cholesterol diet mouse model. Int J. Mol. Sci. 25, 2813 (2024).","journal-title":"Int J. Mol. Sci."},{"key":"1147_CR267","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11869","volume":"7","author":"J Gautheron","year":"2016","unstructured":"Gautheron, J. et al. The necroptosis-inducing kinase RIPK3 dampens adipose tissue inflammation and glucose intolerance. Nat. Commun. 7, 11869 (2016).","journal-title":"Nat. Commun."},{"key":"1147_CR268","doi-asserted-by":"publisher","first-page":"17681","DOI":"10.18632\/oncotarget.6893","volume":"7","author":"S Wang","year":"2016","unstructured":"Wang, S. et al. Increased hepatic receptor interacting protein kinase 3 expression due to impaired proteasomal functions contributes to alcohol-induced steatosis and liver injury. Oncotarget 7, 17681\u201317698 (2016).","journal-title":"Oncotarget"},{"key":"1147_CR269","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.140180","volume":"6","author":"T Miyata","year":"2021","unstructured":"Miyata, T. et al. Differential role of MLKL in alcohol-associated and non-alcohol-associated fatty liver diseases in mice and humans. JCI Insight 6, e140180 (2021).","journal-title":"JCI Insight"},{"key":"1147_CR270","doi-asserted-by":"publisher","first-page":"5220","DOI":"10.7150\/thno.71400","volume":"12","author":"R Guo","year":"2022","unstructured":"Guo, R. et al. Loss of MLKL ameliorates liver fibrosis by inhibiting hepatocyte necroptosis and hepatic stellate cell activation. Theranostics 12, 5220\u20135236 (2022).","journal-title":"Theranostics"},{"key":"1147_CR271","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1111\/jgh.16368","volume":"38","author":"JH Oh","year":"2023","unstructured":"Oh, J. H. et al. Hepatic stellate cells activate and avoid death under necroptosis stimuli: hepatic fibrosis during necroptosis. J. Gastroenterol. Hepatol. 38, 2206\u20132214 (2023).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"1147_CR272","doi-asserted-by":"publisher","first-page":"101446","DOI":"10.1016\/j.jcmgh.2024.101446","volume":"19","author":"M Ortega-Ribera","year":"2025","unstructured":"Ortega-Ribera, M. et al. A novel multi-organ male model of alcohol-induced acute-on-chronic liver failure reveals NET-mediated hepatocellular death, which is prevented by RIPK3 inhibition. Cell Mol. Gastroenterol. Hepatol. 19, 101446 (2025).","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"1147_CR273","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1055\/s-0038-1629924","volume":"38","author":"L Dara","year":"2018","unstructured":"Dara, L. The receptor interacting protein kinases in the liver. Semin. Liver Dis. 38, 73\u201386 (2018).","journal-title":"Semin. Liver Dis."},{"key":"1147_CR274","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/s41420-022-01123-0","volume":"8","author":"Z Li","year":"2022","unstructured":"Li, Z. et al. Inhibition of TWEAK\/Tnfrsf12a axis protects against acute liver failure by suppressing RIPK1-dependent apoptosis. Cell Death Discov. 8, 328 (2022).","journal-title":"Cell Death Discov."},{"key":"1147_CR275","first-page":"305","volume":"119","author":"AB Imaeda","year":"2009","unstructured":"Imaeda, A. B. et al. Acetaminophen-induced hepatotoxicity in mice is dependent on Tlr9 and the Nalp3 inflammasome. J. Clin. Invest. 119, 305\u2013314 (2009).","journal-title":"J. Clin. Invest."},{"key":"1147_CR276","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.taap.2011.03.001","volume":"252","author":"CD Williams","year":"2011","unstructured":"Williams, C. D. et al. Role of the Nalp3 inflammasome in acetaminophen-induced sterile inflammation and liver injury. Toxicol. Appl. Pharmacol. 252, 289\u2013297 (2011).","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"1147_CR277","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1038\/nm1603","volume":"13","author":"CJ Chen","year":"2007","unstructured":"Chen, C. J. et al. Identification of a key pathway required for the sterile inflammatory response triggered by dying cells. Nat. Med. 13, 851\u2013856 (2007).","journal-title":"Nat. Med."},{"key":"1147_CR278","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.taap.2010.07.004","volume":"247","author":"CD Williams","year":"2010","unstructured":"Williams, C. D., Farhood, A. & Jaeschke, H. Role of caspase-1 and interleukin-1\u03b2 in acetaminophen-induced hepatic inflammation and liver injury. Toxicol. Appl. Pharmacol. 247, 169\u2013178 (2010).","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"1147_CR279","doi-asserted-by":"publisher","first-page":"758","DOI":"10.3389\/fimmu.2018.00758","volume":"9","author":"J Luan","year":"2018","unstructured":"Luan, J. et al. NOD-Like receptor protein 3 inflammasome-dependent IL-1\u03b2 accelerated ConA-induced hepatitis. Front. Immunol. 9, 758 (2018).","journal-title":"Front. Immunol."},{"key":"1147_CR280","doi-asserted-by":"publisher","first-page":"6527","DOI":"10.3748\/wjg.v25.i44.6527","volume":"25","author":"H Li","year":"2019","unstructured":"Li, H. et al. Gasdermin D-mediated hepatocyte pyroptosis expands inflammatory responses that aggravate acute liver failure by upregulating monocyte chemotactic protein 1\/CC chemokine receptor-2 to recruit macrophages. World J. Gastroenterol. 25, 6527\u20136540 (2019).","journal-title":"World J. Gastroenterol."},{"key":"1147_CR281","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.jcmgh.2021.04.009","volume":"12","author":"Y Zhu","year":"2021","unstructured":"Zhu, Y. et al. Caspase-11-mediated hepatocytic pyroptosis promotes the progression of nonalcoholic steatohepatitis. Cell Mol. Gastroenterol. Hepatol. 12, 653\u2013664 (2021).","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"1147_CR282","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/labinvest.2012.45","volume":"92","author":"LJ Dixon","year":"2012","unstructured":"Dixon, L. J., Berk, M., Thapaliya, S., Papouchado, B. G. & Feldstein, A. E. Caspase-1-mediated regulation of fibrogenesis in diet-induced steatohepatitis. Lab. Invest. 92, 713\u2013723 (2012).","journal-title":"Lab. Invest."},{"key":"1147_CR283","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1136\/gutjnl-2020-322509","volume":"70","author":"EH Koh","year":"2021","unstructured":"Koh, E. H. et al. Sphingomyelin synthase 1 mediates hepatocyte pyroptosis to trigger non-alcoholic steatohepatitis. Gut 70, 1954\u20131964 (2021).","journal-title":"Gut"},{"key":"1147_CR284","doi-asserted-by":"publisher","first-page":"100330","DOI":"10.1016\/j.jlr.2023.100330","volume":"64","author":"GN Ioannou","year":"2023","unstructured":"Ioannou, G. N. et al. Genetic deletion or pharmacologic inhibition of the Nlrp3 inflammasome did not ameliorate experimental NASH. J. Lipid Res. 64, 100330 (2023).","journal-title":"J. Lipid Res."},{"key":"1147_CR285","doi-asserted-by":"publisher","first-page":"7853482","DOI":"10.1155\/2022\/7853482","volume":"2022","author":"EB Ma","year":"2022","unstructured":"Ma, E. B., Javaid, H. M. A., Jung, D. H., Park, J. H. & Huh, J. Y. Gasdermin D deficiency does not protect mice from high-fat diet-induced glucose intolerance and adipose tissue inflammation. Mediators Inflamm. 2022, 7853482 (2022).","journal-title":"Mediators Inflamm."},{"key":"1147_CR286","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0056100","volume":"8","author":"LJ Dixon","year":"2013","unstructured":"Dixon, L. J., Flask, C. A., Papouchado, B. G., Feldstein, A. E. & Nagy, L. E. Caspase-1 as a central regulator of high fat diet-induced non-alcoholic steatohepatitis. PLoS One 8, e56100 (2013).","journal-title":"PLoS One"},{"key":"1147_CR287","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.semcdb.2023.07.012","volume":"156","author":"K Shkarina","year":"2024","unstructured":"Shkarina, K. & Broz, P. Selective induction of programmed cell death using synthetic biology tools. Semin. Cell Dev. Biol. 156, 74\u201392 (2024).","journal-title":"Semin. Cell Dev. Biol."},{"key":"1147_CR288","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s41573-021-00371-6","volume":"21","author":"M Bekes","year":"2022","unstructured":"Bekes, M., Langley, D. R. & Crews, C. M. PROTAC targeted protein degraders: the past is prologue. Nat. Rev. Drug Discov. 21, 181\u2013200 (2022).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1147_CR289","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.amjms.2023.11.007","volume":"367","author":"U Gupta","year":"2024","unstructured":"Gupta, U., Ruli, T., Buttar, D., Shoreibah, M. & Gray, M. Metabolic dysfunction associated steatotic liver disease: current practice, screening guidelines and management in the primary care setting. Am. J. Med. Sci. 367, 77\u201388 (2024).","journal-title":"Am. J. Med. Sci."},{"key":"1147_CR290","doi-asserted-by":"publisher","first-page":"103910","DOI":"10.1016\/j.drudis.2024.103910","volume":"29","author":"S Wei","year":"2024","unstructured":"Wei, S., Wang, L., Evans, P. C. & Xu, S. NAFLD and NASH: etiology, targets and emerging therapies. Drug Discov. Today 29, 103910 (2024).","journal-title":"Drug Discov. Today"},{"key":"1147_CR291","doi-asserted-by":"publisher","first-page":"197","DOI":"10.7570\/jomes23052","volume":"32","author":"WK Chan","year":"2023","unstructured":"Chan, W. K. et al. Metabolic dysfunction-associated steatotic liver disease (MASLD): a state-of-the-art review. J. Obes. Metab. Syndr. 32, 197\u2013213 (2023).","journal-title":"J. Obes. Metab. Syndr."},{"key":"1147_CR292","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.3350\/cmh.2022.0365","volume":"29","author":"ML Teng","year":"2023","unstructured":"Teng, M. L. et al. Global incidence and prevalence of nonalcoholic fatty liver disease. Clin. Mol. Hepatol. 29, S32\u2013S42 (2023).","journal-title":"Clin. Mol. Hepatol."},{"key":"1147_CR293","doi-asserted-by":"publisher","DOI":"10.1172\/JCI176345","volume":"134","author":"B Mackowiak","year":"2024","unstructured":"Mackowiak, B., Fu, Y., Maccioni, L. & Gao, B. Alcohol-associated liver disease. J. Clin. Invest. 134, e176345 (2024).","journal-title":"J. Clin. Invest."},{"key":"1147_CR294","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1016\/j.jceh.2022.05.004","volume":"12","author":"NA Osna","year":"2022","unstructured":"Osna, N. A., Rasineni, K., Ganesan, M., Donohue, T. M. Jr. & Kharbanda, K. K. Pathogenesis of alcohol-associated liver disease. J. Clin. Exp. Hepatol. 12, 1492\u20131513 (2022).","journal-title":"J. Clin. Exp. Hepatol."},{"key":"1147_CR295","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","volume":"70","author":"SK Asrani","year":"2019","unstructured":"Asrani, S. K., Devarbhavi, H., Eaton, J. & Kamath, P. S. Burden of liver diseases in the world. J. Hepatol. 70, 151\u2013171 (2019).","journal-title":"J. Hepatol."},{"key":"1147_CR296","doi-asserted-by":"publisher","first-page":"101250","DOI":"10.1016\/j.jhepr.2024.101250","volume":"7","author":"J Gratacos-Gines","year":"2025","unstructured":"Gratacos-Gines, J., Arino, S., Sancho-Bru, P., Bataller, R. & Pose, E. MetALD: clinical aspects, pathophysiology and treatment. JHEP Rep. 7, 101250 (2025).","journal-title":"JHEP Rep."},{"key":"1147_CR297","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1056\/NEJMra1506330","volume":"375","author":"KN Lazaridis","year":"2016","unstructured":"Lazaridis, K. N. & LaRusso, N. F. Primary sclerosing cholangitis. N. Engl. J. Med. 375, 1161\u20131170 (2016).","journal-title":"N. Engl. J. Med."},{"key":"1147_CR298","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.medj.2021.03.002","volume":"2","author":"S Gallage","year":"2021","unstructured":"Gallage, S. et al. The therapeutic landscape of hepatocellular carcinoma. Med 2, 505\u2013552 (2021).","journal-title":"Med"},{"key":"1147_CR299","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.trecan.2021.01.012","volume":"7","author":"V Leone","year":"2021","unstructured":"Leone, V., Ali, A., Weber, A., Tschaharganeh, D. F. & Heikenwalder, M. Liver inflammation and hepatobiliary cancers. Trends Cancer 7, 606\u2013623 (2021).","journal-title":"Trends Cancer"},{"key":"1147_CR300","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jhep.2019.09.007","volume":"72","author":"O Clements","year":"2020","unstructured":"Clements, O., Eliahoo, J., Kim, J. U., Taylor-Robinson, S. D. & Khan, S. A. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a systematic review and meta-analysis. J. Hepatol. 72, 95\u2013103 (2020).","journal-title":"J. Hepatol."},{"key":"1147_CR301","doi-asserted-by":"publisher","first-page":"101567","DOI":"10.1016\/j.esmoop.2023.101567","volume":"8","author":"M Ducreux","year":"2023","unstructured":"Ducreux, M. et al. The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 24th ESMO\/World Congress on Gastrointestinal Cancer, Barcelona, 2022. ESMO Open 8, 101567 (2023).","journal-title":"ESMO Open"},{"key":"1147_CR302","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209\u2013249 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"1147_CR303","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jhep.2022.01.020","volume":"77","author":"A Ghallab","year":"2022","unstructured":"Ghallab, A. et al. Interruption of bile acid uptake by hepatocytes after acetaminophen overdose ameliorates hepatotoxicity. J. Hepatol. 77, 71\u201383 (2022).","journal-title":"J. Hepatol."},{"key":"1147_CR304","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1515\/biol-2022-0013","volume":"17","author":"Y Liu","year":"2022","unstructured":"Liu, Y., Hao, H. & Hou, T. Concanavalin A-induced autoimmune hepatitis model in mice: mechanisms and future outlook. Open Life Sci. 17, 91\u2013101 (2022).","journal-title":"Open Life Sci."},{"key":"1147_CR305","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1177\/0023677215572841","volume":"49","author":"F Heymann","year":"2015","unstructured":"Heymann, F., Hamesch, K., Weiskirchen, R. & Tacke, F. The concanavalin A model of acute hepatitis in mice. Lab. Anim. 49, 12\u201320 (2015).","journal-title":"Lab. Anim."},{"key":"1147_CR306","doi-asserted-by":"publisher","first-page":"4904","DOI":"10.3748\/wjg.v25.i33.4904","volume":"25","author":"ML Boland","year":"2019","unstructured":"Boland, M. L. et al. Towards a standard diet-induced and biopsy-confirmed mouse model of non-alcoholic steatohepatitis: impact of dietary fat source. World J. Gastroenterol. 25, 4904\u20134920 (2019).","journal-title":"World J. Gastroenterol."},{"key":"1147_CR307","doi-asserted-by":"publisher","first-page":"770","DOI":"10.3389\/fphys.2019.00770","volume":"10","author":"HK Drescher","year":"2019","unstructured":"Drescher, H. K. et al. The Influence of different fat sources on steatohepatitis and fibrosis development in the western diet mouse model of non-alcoholic steatohepatitis (NASH). Front. Physiol. 10, 770 (2019).","journal-title":"Front. Physiol."},{"key":"1147_CR308","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/iep.12008","volume":"94","author":"M Matsumoto","year":"2013","unstructured":"Matsumoto, M. et al. An improved mouse model that rapidly develops fibrosis in non-alcoholic steatohepatitis. Int. J. Exp. Pathol. 94, 93\u2013103 (2013).","journal-title":"Int. J. Exp. Pathol."},{"key":"1147_CR309","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jhep.2003.09.020","volume":"40","author":"ME Rinella","year":"2004","unstructured":"Rinella, M. E. & Green, R. M. The methionine-choline deficient dietary model of steatohepatitis does not exhibit insulin resistance. J. Hepatol. 40, 47\u201351 (2004).","journal-title":"J. Hepatol."},{"key":"1147_CR310","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.0959-9673.2006.00465.x","volume":"87","author":"QM Anstee","year":"2006","unstructured":"Anstee, Q. M. & Goldin, R. D. Mouse models in non-alcoholic fatty liver disease and steatohepatitis research. Int. J. Exp. Pathol. 87, 1\u201316 (2006).","journal-title":"Int. J. Exp. Pathol."},{"key":"1147_CR311","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.cmet.2018.10.012","volume":"29","author":"MA Febbraio","year":"2019","unstructured":"Febbraio, M. A. et al. Preclinical models for studying NASH-driven HCC: how useful are they? Cell Metab. 29, 18\u201326 (2019).","journal-title":"Cell Metab."},{"key":"1147_CR312","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.jhep.2020.04.011","volume":"73","author":"YA Nevzorova","year":"2020","unstructured":"Nevzorova, Y. A., Boyer-Diaz, Z., Cubero, F. J. & Gracia-Sancho, J. Animal models for liver disease \u2014 a practical approach for translational research. J. Hepatol. 73, 423\u2013440 (2020).","journal-title":"J. Hepatol."},{"key":"1147_CR313","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1111\/j.1530-0277.2011.01472.x","volume":"35","author":"E Gabele","year":"2011","unstructured":"Gabele, E. et al. A new model of interactive effects of alcohol and high-fat diet on hepatic fibrosis. Alcohol. Clin. Exp. Res. 35, 1361\u20131367 (2011).","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"1147_CR314","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1111\/acer.14700","volume":"45","author":"M Schonfeld","year":"2021","unstructured":"Schonfeld, M. et al. A Western diet with alcohol in drinking water recapitulates features of alcohol-associated liver disease in mice. Alcohol. Clin. Exp. Res. 45, 1980\u20131993 (2021).","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"1147_CR315","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/978-1-4939-9420-5_15","volume":"1981","author":"S Van Campenhout","year":"2019","unstructured":"Van Campenhout, S., Van Vlierberghe, H. & Devisscher, L. Common bile duct ligation as model for secondary biliary cirrhosis. Methods Mol. Biol. 1981, 237\u2013247 (2019).","journal-title":"Methods Mol. Biol."},{"key":"1147_CR316","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/0092-8674(93)90380-9","volume":"75","author":"JJ Smit","year":"1993","unstructured":"Smit, J. J. et al. Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell 75, 451\u2013462 (1993).","journal-title":"Cell"},{"key":"1147_CR317","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1177\/0023677215571192","volume":"49","author":"D Scholten","year":"2015","unstructured":"Scholten, D., Trebicka, J., Liedtke, C. & Weiskirchen, R. The carbon tetrachloride model in mice. Lab. Anim. 49, 4\u201311 (2015).","journal-title":"Lab. Anim."},{"key":"1147_CR318","doi-asserted-by":"publisher","first-page":"113042","DOI":"10.1016\/j.yexcr.2022.113042","volume":"412","author":"CY Gu","year":"2022","unstructured":"Gu, C. Y. & Lee, T. K. W. Preclinical mouse models of hepatocellular carcinoma: an overview and update. Exp. Cell Res. 412, 113042 (2022).","journal-title":"Exp. Cell Res."},{"key":"1147_CR319","doi-asserted-by":"publisher","first-page":"101417","DOI":"10.1016\/j.jcmgh.2024.101417","volume":"19","author":"W Ma","year":"2024","unstructured":"Ma, W., Zhang, J., Chen, W., Liu, N. & Wu, T. Notch-driven cholangiocarcinogenesis involves the hippo pathway effector TAZ via METTL3-m6A-YTHDF1. Cell Mol. Gastroenterol. Hepatol. 19, 101417 (2024).","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"1147_CR320","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-04240-3","volume":"12","author":"S Dhani","year":"2021","unstructured":"Dhani, S., Zhao, Y. & Zhivotovsky, B. A long way to go: caspase inhibitors in clinical use. Cell Death Dis. 12, 949 (2021).","journal-title":"Cell Death Dis."},{"key":"1147_CR321","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.molcel.2014.10.021","volume":"56","author":"P Mandal","year":"2014","unstructured":"Mandal, P. et al. RIP3 induces apoptosis independent of pronecrotic kinase activity. Mol. Cell 56, 481\u2013495 (2014).","journal-title":"Mol. Cell"},{"key":"1147_CR322","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.cell.2011.11.031","volume":"148","author":"L Sun","year":"2012","unstructured":"Sun, L. et al. Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase. Cell 148, 213\u2013227 (2012).","journal-title":"Cell"},{"key":"1147_CR323","doi-asserted-by":"publisher","first-page":"2738","DOI":"10.1126\/sciimmunol.aat2738","volume":"3","author":"JK Rathkey","year":"2018","unstructured":"Rathkey, J. K. et al. Chemical disruption of the pyroptotic pore-forming protein gasdermin D inhibits inflammatory cell death and sepsis. Sci. Immunol. 3, 2738 (2018).","journal-title":"Sci. Immunol."},{"key":"1147_CR324","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/nm1196","volume":"11","author":"AJ Muller","year":"2005","unstructured":"Muller, A. J., DuHadaway, J. B., Donover, P. S., Sutanto-Ward, E. & Prendergast, G. C. Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy. Nat. Med. 11, 312\u2013319 (2005).","journal-title":"Nat. Med."},{"key":"1147_CR325","doi-asserted-by":"publisher","first-page":"5039","DOI":"10.1016\/j.bmcl.2005.07.077","volume":"15","author":"X Teng","year":"2005","unstructured":"Teng, X. et al. Structure-activity relationship study of novel necroptosis inhibitors. Bioorg. Med. Chem. Lett. 15, 5039\u20135044 (2005).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"1147_CR326","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1021\/acs.jmedchem.2c01621","volume":"66","author":"CR Gardner","year":"2023","unstructured":"Gardner, C. R. et al. From (Tool)bench to bedside: the potential of necroptosis inhibitors. J. Med. Chem. 66, 2361\u20132385 (2023).","journal-title":"J. Med. Chem."},{"key":"1147_CR327","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1128\/MCB.24.4.1464-1469.2004","volume":"24","author":"K Newton","year":"2004","unstructured":"Newton, K., Sun, X. & Dixit, V. M. Kinase RIP3 is dispensable for normal NF-\u03baBs, signaling by the B-cell and T-cell receptors, tumor necrosis factor receptor 1, and toll-like receptors 2 and 4. Mol. Cell Biol. 24, 1464\u20131469 (2004).","journal-title":"Mol. Cell Biol."},{"key":"1147_CR328","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.immuni.2013.06.018","volume":"39","author":"JM Murphy","year":"2013","unstructured":"Murphy, J. M. et al. The pseudokinase MLKL mediates necroptosis via a molecular switch mechanism. Immunity 39, 443\u2013453 (2013).","journal-title":"Immunity"},{"key":"1147_CR329","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1038\/cr.2013.91","volume":"23","author":"J Wu","year":"2013","unstructured":"Wu, J. et al. Mlkl knockout mice demonstrate the indispensable role of Mlkl in necroptosis. Cell Res. 23, 994\u20131006 (2013).","journal-title":"Cell Res."},{"key":"1147_CR330","doi-asserted-by":"publisher","first-page":"7753","DOI":"10.1073\/pnas.1401857111","volume":"111","author":"WJ Kaiser","year":"2014","unstructured":"Kaiser, W. J. et al. RIP1 suppresses innate immune necrotic as well as apoptotic cell death during mammalian parturition. Proc. Natl Acad. Sci. USA 111, 7753\u20137758 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1147_CR331","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1126\/science.1249361","volume":"343","author":"K Newton","year":"2014","unstructured":"Newton, K. et al. Activity of protein kinase RIPK3 determines whether cells die by necroptosis or apoptosis. Science 343, 1357\u20131360 (2014).","journal-title":"Science"},{"key":"1147_CR332","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.4049\/jimmunol.1400590","volume":"193","author":"A Polykratis","year":"2014","unstructured":"Polykratis, A. et al. Cutting edge: RIPK1 Kinase inactive mice are viable and protected from TNF-induced necroptosis in vivo. J. Immunol. 193, 1539\u20131543 (2014).","journal-title":"J. Immunol."},{"key":"1147_CR333","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23474-5","volume":"12","author":"LR Garcia","year":"2021","unstructured":"Garcia, L. R. et al. Ubiquitylation of MLKL at lysine 219 positively regulates necroptosis-induced tissue injury and pathogen clearance. Nat. Commun. 12, 3364 (2021).","journal-title":"Nat. Commun."},{"key":"1147_CR334","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nm.3806","volume":"21","author":"RC Coll","year":"2015","unstructured":"Coll, R. C. et al. A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases. Nat. Med. 21, 248\u2013255 (2015).","journal-title":"Nat. Med."},{"key":"1147_CR335","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.4049\/jimmunol.1600035","volume":"197","author":"MJ Primiano","year":"2016","unstructured":"Primiano, M. J. et al. Efficacy and pharmacology of the NLRP3 inflammasome inhibitor CP-456,773 (CRID3) in murine models of dermal and pulmonary inflammation. J. Immunol. 197, 2421\u20132433 (2016).","journal-title":"J. Immunol."},{"key":"1147_CR336","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1002\/cmdc.201700270","volume":"12","author":"JR Hill","year":"2017","unstructured":"Hill, J. R. et al. Sulfonylureas as concomitant insulin secretagogues and NLRP3 inflammasome inhibitors. ChemMedChem 12, 1449\u20131457 (2017).","journal-title":"ChemMedChem"},{"key":"1147_CR337","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1083\/jcb.200903124","volume":"187","author":"M Lamkanfi","year":"2009","unstructured":"Lamkanfi, M. et al. Glyburide inhibits the cryopyrin\/Nalp3 inflammasome. J. Cell Biol. 187, 61\u201370 (2009).","journal-title":"J. Cell Biol."},{"key":"1147_CR338","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1083\/jcb.137.1.221","volume":"137","author":"SM Mariani","year":"1997","unstructured":"Mariani, S. M., Matiba, B., Armandola, E. A. & Krammer, P. H. Interleukin 1\u03b2-converting enzyme related proteases\/caspases are involved in TRAIL-induced apoptosis of myeloma and leukemia cells. J. Cell Biol. 137, 221\u2013229 (1997).","journal-title":"J. Cell Biol."},{"key":"1147_CR339","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1124\/jpet.106.111344","volume":"321","author":"W Wannamaker","year":"2007","unstructured":"Wannamaker, W. et al. (S)-1-((S)-2-{[1-(4-Amino-3-chloro-phenyl)-methanoyl]-amino}-3,3-dimethyl-butanoyl)-pyrrolidine-2-carboxylic acid ((2 R,3 S)-2-ethoxy-5-oxo-tetrahydro-furan-3-yl)-amide (VX-765), an orally available selective interleukin (IL)-converting enzyme\/caspase-1 inhibitor, exhibits potent anti-inflammatory activities by Inhibiting the release of IL-1\u03b2 and IL-18. J. Pharmacol. Exp. Ther. 321, 509\u2013516 (2007).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"1147_CR340","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1038\/s41590-020-0669-6","volume":"21","author":"JJ Hu","year":"2020","unstructured":"Hu, J. J. et al. FDA-approved disulfiram inhibits pyroptosis by blocking gasdermin D pore formation. Nat. Immunol. 21, 736\u2013745 (2020).","journal-title":"Nat. Immunol."},{"key":"1147_CR341","doi-asserted-by":"publisher","first-page":"16115","DOI":"10.3390\/ijms232416115","volume":"23","author":"S Wei","year":"2022","unstructured":"Wei, S., Feng, M. & Zhang, S. Molecular characteristics of cell pyroptosis and its inhibitors: a review of activation, regulation, and inhibitors. Int J. Mol. Sci. 23, 16115 (2022).","journal-title":"Int J. Mol. Sci."},{"key":"1147_CR342","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/imr.12534","volume":"277","author":"SM Man","year":"2017","unstructured":"Man, S. M., Karki, R. & Kanneganti, T. D. Molecular mechanisms and functions of pyroptosis, inflammatory caspases and inflammasomes in infectious diseases. Immunol. Rev. 277, 61\u201375 (2017).","journal-title":"Immunol. Rev."},{"key":"1147_CR343","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/nature10558","volume":"479","author":"N Kayagaki","year":"2011","unstructured":"Kayagaki, N. et al. Non-canonical inflammasome activation targets caspase-11. Nature 479, 117\u2013121 (2011).","journal-title":"Nature"},{"key":"1147_CR344","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/s41392-023-01606-1","volume":"8","author":"S Sun","year":"2023","unstructured":"Sun, S., Shen, J., Jiang, J., Wang, F. & Min, J. Targeting ferroptosis opens new avenues for the development of novel therapeutics. Signal. Transduct. Target. Ther. 8, 372 (2023).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"1147_CR345","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.06557","volume":"4","author":"X Rong","year":"2015","unstructured":"Rong, X. et al. Lpcat3-dependent production of arachidonoyl phospholipids is a key determinant of triglyceride secretion. eLife 4, e06557 (2015).","journal-title":"eLife"},{"key":"1147_CR346","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1038\/s41418-024-01348-9","volume":"31","author":"C Peleman","year":"2024","unstructured":"Peleman, C. et al. Ferroptosis is a targetable detrimental factor in metabolic dysfunction-associated steatotic liver disease. Cell Death Differ. 31, 1113\u20131126 (2024).","journal-title":"Cell Death Differ."},{"key":"1147_CR347","doi-asserted-by":"publisher","first-page":"aad6872","DOI":"10.1126\/science.aad6872","volume":"354","author":"Y Wang","year":"2016","unstructured":"Wang, Y. et al. A nuclease that mediates cell death induced by DNA damage and poly(ADP-ribose) polymerase-1. Science 354, aad6872 (2016).","journal-title":"Science"},{"key":"1147_CR348","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1126\/science.1072221","volume":"297","author":"SW Yu","year":"2002","unstructured":"Yu, S. W. et al. Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor. Science 297, 259\u2013263 (2002).","journal-title":"Science"},{"key":"1147_CR349","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1016\/j.jhep.2016.11.020","volume":"66","author":"K Huang","year":"2017","unstructured":"Huang, K. et al. PARP1-mediated PPAR\u03b1 poly(ADP-ribosyl)ation suppresses fatty acid oxidation in non-alcoholic fatty liver disease. J. Hepatol. 66, 962\u2013977 (2017).","journal-title":"J. Hepatol."},{"key":"1147_CR350","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.jhep.2016.10.023","volume":"66","author":"P Mukhopadhyay","year":"2017","unstructured":"Mukhopadhyay, P. et al. PARP inhibition protects against alcoholic and non-alcoholic steatohepatitis. J. Hepatol. 66, 589\u2013600 (2017).","journal-title":"J. Hepatol."},{"key":"1147_CR351","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.cmet.2011.03.004","volume":"13","author":"P Bai","year":"2011","unstructured":"Bai, P. et al. PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation. Cell Metab. 13, 461\u2013468 (2011).","journal-title":"Cell Metab."},{"key":"1147_CR352","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1083\/jcb.200606027","volume":"176","author":"TA Fuchs","year":"2007","unstructured":"Fuchs, T. A. et al. Novel cell death program leads to neutrophil extracellular traps. J. Cell Biol. 176, 231\u2013241 (2007).","journal-title":"J. Cell Biol."},{"key":"1147_CR353","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1084\/jem.20100239","volume":"207","author":"P Li","year":"2010","unstructured":"Li, P. et al. PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular traps. J. Exp. Med. 207, 1853\u20131862 (2010).","journal-title":"J. Exp. Med."},{"key":"1147_CR354","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1083\/jcb.201006052","volume":"191","author":"V Papayannopoulos","year":"2010","unstructured":"Papayannopoulos, V., Metzler, K. D., Hakkim, A. & Zychlinsky, A. Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps. J. Cell Biol. 191, 677\u2013691 (2010).","journal-title":"J. Cell Biol."},{"key":"1147_CR355","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s00428-022-03330-7","volume":"481","author":"S Arelaki","year":"2022","unstructured":"Arelaki, S. et al. Neutrophil extracellular traps enriched with IL-1\u03b2 and IL-17A participate in the hepatic inflammatory process of patients with non-alcoholic steatohepatitis. Virchows Arch. 481, 455\u2013465 (2022).","journal-title":"Virchows Arch."},{"key":"1147_CR356","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1002\/hep.29914","volume":"68","author":"DJ van der Windt","year":"2018","unstructured":"van der Windt, D. J. et al. Neutrophil extracellular traps promote inflammation and development of hepatocellular carcinoma in nonalcoholic steatohepatitis. Hepatology 68, 1347\u20131360 (2018).","journal-title":"Hepatology"},{"key":"1147_CR357","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1126\/science.abf0529","volume":"375","author":"P Tsvetkov","year":"2022","unstructured":"Tsvetkov, P. et al. Copper induces cell death by targeting lipoylated TCA cycle proteins. Science 375, 1254\u20131261 (2022).","journal-title":"Science"},{"key":"1147_CR358","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/S0140-6736(07)60196-2","volume":"369","author":"A Ala","year":"2007","unstructured":"Ala, A., Walker, A. P., Ashkan, K., Dooley, J. S. & Schilsky, M. L. Wilson\u2019s disease. Lancet 369, 397\u2013408 (2007).","journal-title":"Lancet"},{"key":"1147_CR359","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1034\/j.1600-0676.2003.00824.x","volume":"23","author":"P Ferenci","year":"2003","unstructured":"Ferenci, P. et al. Diagnosis and phenotypic classification of Wilson disease. Liver Int. 23, 139\u2013142 (2003).","journal-title":"Liver Int."},{"key":"1147_CR360","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/s41392-022-01229-y","volume":"7","author":"L Chen","year":"2022","unstructured":"Chen, L., Min, J. & Wang, F. Copper homeostasis and cuproptosis in health and disease. Signal. Transduct. Target. Ther. 7, 378 (2022).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"1147_CR361","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1007\/s00018-016-2203-4","volume":"73","author":"K Moriwaki","year":"2016","unstructured":"Moriwaki, K. & Chan, F. K. Necroptosis-independent signaling by the RIP kinases in inflammation. Cell Mol. Life Sci. 73, 2325\u20132334 (2016).","journal-title":"Cell Mol. Life Sci."},{"key":"1147_CR362","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.cell.2017.03.011","volume":"169","author":"BP Daniels","year":"2017","unstructured":"Daniels, B. P. et al. RIPK3 restricts viral pathogenesis via cell death-independent neuroinflammation. Cell 169, 301\u2013313.e11 (2017).","journal-title":"Cell"},{"key":"1147_CR363","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1016\/j.celrep.2017.02.015","volume":"18","author":"K Moriwaki","year":"2017","unstructured":"Moriwaki, K., Balaji, S., Bertin, J., Gough, P. J. & Chan, F. K. Distinct kinase-independent role of RIPK3 in CD11c+ mononuclear phagocytes in cytokine-induced tissue repair. Cell Rep. 18, 2441\u20132451 (2017).","journal-title":"Cell Rep."},{"key":"1147_CR364","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0024772","volume":"6","author":"MS Matter","year":"2011","unstructured":"Matter, M. S. et al. Destruction of lymphoid organ architecture and hepatitis caused by CD4+ T cells. PLoS One 6, e24772 (2011).","journal-title":"PLoS One"},{"key":"1147_CR365","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1084\/jem.164.4.1075","volume":"164","author":"RM Zinkernagel","year":"1986","unstructured":"Zinkernagel, R. M. et al. T cell-mediated hepatitis in mice infected with lymphocytic choriomeningitis virus. Liver cell destruction by H-2 class I-restricted virus-specific cytotoxic T cells as a physiological correlate of the 51Cr-release assay? J. Exp. Med. 164, 1075\u20131092 (1986).","journal-title":"J. Exp. Med."},{"key":"1147_CR366","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1126\/science.1235214","volume":"340","author":"JR Teijaro","year":"2013","unstructured":"Teijaro, J. R. et al. Persistent LCMV infection is controlled by blockade of type I interferon signaling. Science 340, 207\u2013211 (2013).","journal-title":"Science"},{"key":"1147_CR367","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1126\/science.1235208","volume":"340","author":"EB Wilson","year":"2013","unstructured":"Wilson, E. B. et al. Blockade of chronic type I interferon signaling to control persistent LCMV infection. Science 340, 202\u2013207 (2013).","journal-title":"Science"},{"key":"1147_CR368","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05635-0","volume":"14","author":"SP Preston","year":"2023","unstructured":"Preston, S. P. et al. A necroptosis-independent function of RIPK3 promotes immune dysfunction and prevents control of chronic LCMV infection. Cell Death Dis. 14, 123 (2023).","journal-title":"Cell Death Dis."},{"key":"1147_CR369","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1002\/hep.32756","volume":"77","author":"MB Afonso","year":"2023","unstructured":"Afonso, M. B. et al. RIPK3 dampens mitochondrial bioenergetics and lipid droplet dynamics in metabolic liver disease. Hepatology 77, 1319\u20131334 (2023).","journal-title":"Hepatology"},{"key":"1147_CR370","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1126\/science.1172308","volume":"325","author":"DW Zhang","year":"2009","unstructured":"Zhang, D. W. et al. RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis. Science 325, 332\u2013336 (2009).","journal-title":"Science"},{"key":"1147_CR371","doi-asserted-by":"publisher","first-page":"4465","DOI":"10.1007\/s11357-025-01553-5","volume":"47","author":"S Mohammed","year":"2025","unstructured":"Mohammed, S. et al. Impact of Mlkl or Ripk3 deletion on age-associated liver inflammation, metabolic health, and lifespan. Geroscience 47, 4465\u20134483 (2025).","journal-title":"Geroscience"},{"key":"1147_CR372","doi-asserted-by":"publisher","first-page":"1512968","DOI":"10.3389\/fphar.2025.1512968","volume":"16","author":"Y Wang","year":"2025","unstructured":"Wang, Y. et al. MLKL as an emerging machinery for modulating organelle dynamics: regulatory mechanisms, pathophysiological significance, and targeted therapeutics. Front. Pharmacol. 16, 1512968 (2025).","journal-title":"Front. Pharmacol."},{"key":"1147_CR373","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1083\/jcb.201810014","volume":"218","author":"K Sai","year":"2019","unstructured":"Sai, K., Parsons, C., House, J. S., Kathariou, S. & Ninomiya-Tsuji, J. Necroptosis mediators RIPK3 and MLKL suppress intracellular Listeria replication independently of host cell killing. J. Cell Biol. 218, 1994\u20132005 (2019).","journal-title":"J. Cell Biol."},{"key":"1147_CR374","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/s41418-021-00924-7","volume":"29","author":"S Yoon","year":"2022","unstructured":"Yoon, S., Bogdanov, K. & Wallach, D. Site-specific ubiquitination of MLKL targets it to endosomes and targets Listeria and Yersinia to the lysosomes. Cell Death Differ. 29, 306\u2013322 (2022).","journal-title":"Cell Death Differ."},{"key":"1147_CR375","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.immuni.2017.06.001","volume":"47","author":"S Yoon","year":"2017","unstructured":"Yoon, S., Kovalenko, A., Bogdanov, K. & Wallach, D. MLKL, the protein that mediates necroptosis, also regulates endosomal trafficking and extracellular vesicle generation. Immunity 47, 51\u201365.e7 (2017).","journal-title":"Immunity"},{"key":"1147_CR376","doi-asserted-by":"publisher","first-page":"4759","DOI":"10.7150\/thno.54072","volume":"11","author":"C Zhan","year":"2021","unstructured":"Zhan, C., Huang, M., Yang, X. & Hou, J. MLKL: functions beyond serving as the executioner of necroptosis. Theranostics 11, 4759\u20134769 (2021).","journal-title":"Theranostics"},{"key":"1147_CR377","doi-asserted-by":"publisher","DOI":"10.26508\/lsa.202302446","volume":"8","author":"H Tye","year":"2025","unstructured":"Tye, H. et al. Divergent roles of RIPK3 and MLKL in high-fat diet-induced obesity and MAFLD in mice. Life Sci. Alliance 8, e202302446 (2025).","journal-title":"Life Sci. Alliance"},{"key":"1147_CR378","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.jhep.2019.11.008","volume":"72","author":"A Majdi","year":"2020","unstructured":"Majdi, A. et al. Inhibition of receptor-interacting protein kinase 1 improves experimental non-alcoholic fatty liver disease. J. Hepatol. 72, 627\u2013635 (2020).","journal-title":"J. Hepatol."},{"key":"1147_CR379","doi-asserted-by":"publisher","first-page":"96782","DOI":"10.3748\/wjg.v31.i6.96782","volume":"31","author":"HN Xuan Yuan","year":"2025","unstructured":"Xuan Yuan, H. N. et al. Adenosine triphosphate-binding pocket inhibitor for mixed lineage kinase domain-like protein attenuated alcoholic liver disease via necroptosis-independent pathway. World J. Gastroenterol. 31, 96782 (2025).","journal-title":"World J. Gastroenterol."},{"key":"1147_CR380","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.aaw3423","volume":"12","author":"W Fan","year":"2019","unstructured":"Fan, W. et al. Flotillin-mediated endocytosis and ALIX-syntenin-1-mediated exocytosis protect the cell membrane from damage caused by necroptosis. Sci. Signal 12, eaaw3423 (2019).","journal-title":"Sci. Signal"},{"key":"1147_CR381","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.cell.2017.03.020","volume":"169","author":"YN Gong","year":"2017","unstructured":"Gong, Y. N. et al. ESCRT-III acts downstream of MLKL to regulate necroptotic cell death and its consequences. Cell 169, 286\u2013300.e16 (2017).","journal-title":"Cell"},{"key":"1147_CR382","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.cell.2024.11.018","volume":"188","author":"SS Wright","year":"2025","unstructured":"Wright, S. S. et al. Transplantation of gasdermin pores by extracellular vesicles propagates pyroptosis to bystander cells. Cell 188, 280\u2013291.er17 (2025).","journal-title":"Cell"},{"key":"1147_CR383","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-58175-w","volume":"16","author":"BF Roeck","year":"2025","unstructured":"Roeck, B. F. et al. Ferroptosis spreads to neighboring cells via plasma membrane contacts. Nat. Commun. 16, 2951 (2025).","journal-title":"Nat. Commun."},{"key":"1147_CR384","doi-asserted-by":"publisher","first-page":"jcs220996","DOI":"10.1242\/jcs.220996","volume":"132","author":"D Frank","year":"2019","unstructured":"Frank, D., Vaux, D. L., Murphy, J. M., Vince, J. E. & Lindqvist, L. M. Activated MLKL attenuates autophagy following its translocation to intracellular membranes. J. Cell Sci. 132, jcs220996 (2019).","journal-title":"J. Cell Sci."},{"key":"1147_CR385","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1080\/15548627.2018.1474314","volume":"14","author":"M Mauthe","year":"2018","unstructured":"Mauthe, M. et al. Chloroquine inhibits autophagic flux by decreasing autophagosome-lysosome fusion. Autophagy 14, 1435\u20131455 (2018).","journal-title":"Autophagy"},{"key":"1147_CR386","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1038\/s41418-024-01314-5","volume":"31","author":"X Yu","year":"2024","unstructured":"Yu, X. et al. MLKL promotes hepatocarcinogenesis through inhibition of AMPK-mediated autophagy. Cell Death Differ. 31, 1085\u20131098 (2024).","journal-title":"Cell Death Differ."}],"container-title":["Nature Reviews Gastroenterology & Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41575-025-01147-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41575-025-01147-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41575-025-01147-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:02:11Z","timestamp":1774915331000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41575-025-01147-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,24]]},"references-count":386,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["1147"],"URL":"https:\/\/doi.org\/10.1038\/s41575-025-01147-8","relation":{},"ISSN":["1759-5045","1759-5053"],"issn-type":[{"value":"1759-5045","type":"print"},{"value":"1759-5053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,24]]},"assertion":[{"value":"21 October 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}